Other necrotizing vasculopathies

M13_NECROVASC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M31 Cause of death: ICD-10 — M31 2 out of 7 registries used, show all original rules.	2713
4. Check minimum number of events None	2713
5. Include endpoints M13_HYPERANG M13_HTROMBMICROANG M13_MIDGRANULOMA M13_WEGENER M13_TAKAYASU M13_GIANTCELL M13_MICROPOLYANG M13_NECROVASCNAS	2849
6. Filter based on genotype QC (FinnGen only)	2770

Control definitions (FinnGen only)

Control exclude: M13_SYSTCONNECT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M30-M36
Name in latin: Aliae angiopathiae necroticantes

NAME	M13_NECROVASC
CONTROL_EXCLUDE	M13_SYSTCONNECT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_HYPERANG\|M13_HTROMBMICROANG\|M13_MIDGRANULOMA\|M13_WEGENER\|M13_TAKAYASU\|M13_GIANTCELL\|M13_MICROPOLYANG\|M13_NECROVASCNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M31
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M31
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other necrotizing vasculopathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2770	1623	1147
Unadjusted period prevalence (%)	0.55	0.58	0.53
Median age at first event (years)	65.83	65.21	66.69

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2849: Matched controls
28490

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

PAW37

NOMESCO Finland

Biopsy of temporal artery

482.8

307.7

608

H02AB06

ATC

prednisolone; systemic

10.5

307.7

2425

10030

L04AA06

ATC

mycophenolic acid; systemic

25.3

307.7

294

129

M31.5

ICD-10 Finland

Giant cell arteritis with polymyalgia rheumatica

3210.2

307.7

1353

M05BA04

ATC

alendronic acid; oral

6.4

307.7

807

1658

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

7.9

307.7

523

790

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

11.9

307.7

1155

1547

M31.3

ICD-10 Finland

Wegener granulomatosis

5798.2

307.7

494

L04AX01

ATC

azathioprine; systemic

18.3

307.7

616

424

M31.6

ICD-10 Finland

Other giant cell arteritis

1087.1

307.7

378

L04AX03

ATC

methotrexate; systemic

8.6

307.7

832

1304

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

6.0

307.7

1947

7525

M35.3

ICD-10 Finland

Polymyalgia rheumatica

37.5

307.7

623

211

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

7.3

307.7

578

960

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

1657.5

306.7

293

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

19.7

304.9

241

133

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

13.4

301.5

296

245

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

+∞

214.3

203

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.2

203.1

378

686

R50.9

ICD-10 Finland

Fever, unspecified

3.9

203.0

767

2473

L01AA01

ATC

cyclophosphamide; systemic

38.4

202.7

125

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.3

200.4

1881

10521

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

6.8

192.9

325

533

M31.1

ICD-10 Finland

Thrombotic microangiopathy

2059.1

189.6

182

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

183.3

174

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.4

178.5

390

818

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.1

173.6

219

257

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

9.1

172.2

218

257

M31.7

ICD-10 Finland

Microscopic polyangiitis

+∞

168.4

160

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

50.2

167.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.2

157.4

246

371

DHA10

NOMESCO Finland

Biopsy of cavity of nose

18.9

151.1

120

ZX120

NOMESCO Finland

Intravenous

3.9

149.5

519

1553

I77.6

ICD-10 Finland

Arteritis, unspecified

180.8

148.1

154

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

148.1

604

2012

A02BC02

ATC

pantoprazole; systemic

3.4

147.3

2328

16137

M31.8

ICD-10 Finland

Other specified necrotizing vasculopathies

+∞

146.1

139

H02AB07

ATC

prednisone; oral

3.3

145.4

664

2372

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

133.5

625

2256

N08.5*M31.7

ICD-10 Finland

Glomerular disease states in microscopic polyangiitis

+∞

133.4

127

M35.1

ICD-10 Finland

Other overlap syndromes

+∞

130.2

124

TGC00

NOMESCO Finland

Bronchial lavation

7.1

125.7

197

297

TK800

NOMESCO Finland

Hemodialysis

7.8

120.2

172

234

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

11.6

117.2

122

109

Z94.0

ICD-10 Finland

Kidney transplant status

13.0

116.7

113

M31.0

ICD-10 Finland

Hypersensitivity angiitis

+∞

114.3

109

L88

ICPC

Rheumatoid/seropositive arthritis

5.5

114.0

233

456

R51.80

ICD-10 Finland

Headache

3.0

113.8

612

2375

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

4.1

112.8

337

898

N08.5

ICD-10 Finland

Glomerular disorders in systemic connective tissue disorders

+∞

110.1

105

A11CC03

ATC

alfacalcidol; systemic

6.6

109.6

182

291

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.5

107.9

1025

5277

P01BA02

ATC

hydroxychloroquine; oral

3.7

103.6

357

1050

Z49.1

ICD-10 Finland

Extracorporeal dialysis

9.1

103.3

128

146

H02AB04

ATC

methylprednisolone; systemic

2.8

97.8

605

2514

A12AA04

ATC

calcium carbonate; oral

7.9

92.9

130

172

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

92.2

843

4213

127

Kela drug reimbursment

Transplant complication

9.0

90.8

114

132

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

456.8

89.7

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

17.0

87.7

1XC02, ,

NOMESCO Finland

13.4

86.4

M13.9

ICD-10 Finland

Arthritis, unspecified

3.5

85.5

322

1000

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

12.1

85.2

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

13.0

84.8

A10AC01

ATC

insulin (human); parenteral

3.3

84.1

355

1184

ZX108

NOMESCO Finland

Inhalation

13.0

83.0

L01BA01

ATC

methotrexate; systemic

4.6

81.2

200

457

L04AC07

ATC

tocilizumab; parenteral

29.0

80.6

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.1

79.2

362

1264

KA1AE

NOMESCO Finland

Kidney ultrasound examination

5.4

78.6

159

307

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

17.7

78.4

N18.0

ICD-10 Finland

End-stage renal disease

8.9

78.3

113

C03CA01

ATC

furosemide; systemic

2.1

75.4

1183

7242

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

75.4

282

870

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

9.2

75.2

103

M31.4

ICD-10 Finland

Aortic arch syndrome [Takayasu]

+∞

73.2

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.9

73.2

166

354

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.4

72.3

283

898

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

131.9

72.3

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.2

71.8

311

1050

WW400

NOMESCO Finland

Plasmaferesis

113.0

71.2

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.3

70.7

292

957

B03XA02

ATC

darbepoetin alfa; parenteral

5.4

70.4

143

277

N18.8

ICD-10 Finland

Other chronic renal failure

5.0

68.7

154

325

N08.5*M31.0

ICD-10 Finland

Glomerular disorders in Goodpasture's syndrome

+∞

68.0

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.6

67.5

232

676

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

67.2

650

3269

V03AE02

ATC

sevelamer; oral

15.6

66.6

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

14.7

65.7

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.7

65.7

223

644

L04AD01

ATC

ciclosporin; systemic

6.7

65.7

106

164

M05BA07

ATC

risedronic acid; oral

4.0

65.1

191

498

137

Kela drug reimbursment

Uraemia requiring dialysis

10.2

64.8

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

5.3

64.0

132

259

4476A

ICD-9 Finland

Other disorders of arteries and arterioles, Arteritis, unspecified

+∞

63.8

H26.3

ICD-10 Finland

Drug-induced cataract

12.7

63.3

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

63.1

999

6044

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

9.8

62.0

J01MA14

ATC

moxifloxacin; systemic

2.7

61.8

367

1470

L04AD02

ATC

tacrolimus; systemic

9.9

61.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.1

61.5

273

932

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

7.6

61.2

117

TPX00

NOMESCO Finland

Biopsy of artery or vein

158.4

59.1

Z49.0

ICD-10 Finland

Preparatory care for dialysis

8.6

58.9

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

57.8

441

1990

J01MA12

ATC

levofloxacin; systemic

2.1

57.6

656

3498

N08.5*M31.1

ICD-10 Finland

Glomerular disorders in thrombotic thrombocytopenic purpura

+∞

55.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

55.3

1224

8187

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.5

55.0

381

1641

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

54.9

607

3194

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

11.2

52.0

J01FF01

ATC

clindamycin; systemic

1.9

51.8

853

5162

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.5

51.1

373

1644

AA1AD

NOMESCO Finland

CT of head and brain

1.9

50.4

942

5932

Z49.2

ICD-10 Finland

Other dialysis

10.4

50.3

H47.0

ICD-10 Finland

Disorders of optic nerve, not elsewhere classified

12.8

49.5

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.4

48.7

385

1757

JN4AD

NOMESCO Finland

Body CT examination

2.4

48.3

385

1763

J01DB01

ATC

cefalexin; oral

2.1

48.2

2353

19777

H02AB09

ATC

hydrocortisone; systemic

4.7

47.8

114

253

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

+∞

47.0

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

46.8

648

3677

L04AA13

ATC

[U] leflunomide

4.5

46.7

116

266

V03AE01

ATC

polystyrene sulfonate; oral

6.1

46.6

135

M30.0

ICD-10 Finland

Polyarteritis nodosa

465.2

46.4

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

46.1

383

1783

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

+∞

46.0

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

45.8

300

1254

B05DA

ATC

Isotonic solutions

9.3

45.7

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.0

45.3

217

771

N02AX02

ATC

tramadol; systemic, rectal

1.7

45.0

1301

9248

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

45.0

297

1246

D69.0

ICD-10 Finland

Allergic purpura

9.2

44.3

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

15.2

44.3

J01MA02

ATC

ciprofloxacin; systemic

1.7

43.6

1191

8310

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

5.4

43.6

162

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.5

43.5

152

446

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

42.9

408

2006

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

42.7

265

1078

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

42.2

325

1461

XX9XE

NOMESCO Finland

Other ultrasound examination

9.8

42.2

N03AX16

ATC

[U] pregabalin

1.9

41.4

732

4479

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.2

41.3

112

275

A02BC01

ATC

omeprazole; systemic

1.8

41.2

865

5576

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

40.7

761

4735

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

40.7

378

1840

L04AA01

ATC

[U] ciclosporin

5.8

40.5

133

Z3231

NOMESCO Finland

Registered nurse

1.8

40.4

838

5376

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

40.3

342

1603

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

40.2

1436

10699

R06.0

ICD-10 Finland

Dyspnoea

1.8

40.2

865

5607

B05DB

ATC

Hypertonic solutions

9.0

39.9

C08CA01

ATC

amlodipine; oral

1.7

39.7

1254

9035

N08.5*M32.1

ICD-10 Finland

Glomerular disorders in systemic lupus erythematosus

+∞

39.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.3

39.2

327

1521

WW200

NOMESCO Finland

Immunization

4.0

38.5

111

285

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

38.3

237

962

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

37.0

293

1331

M05BX04

ATC

denosumab; parenteral

2.5

37.0

256

1095

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

9.7

36.8

H65.2

ICD-10 Finland

Chronic serous otitis media

5.5

36.0

130

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.3

35.7

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

11.0

35.6

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

5.0

35.4

158

TK810

NOMESCO Finland

Hemofiltration

9.1

35.1

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

35.1

200

778

N01

ICPC

Headache

2.3

35.1

300

1407

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

35.1

573

3399

B03XA01

ATC

erythropoietin; parenteral

6.5

35.0

H57.1

ICD-10 Finland

Ocular pain

3.3

34.7

132

409

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

34.6

676

4230

Z2446

NOMESCO Finland

Social worker

2.5

34.6

224

928

TK820

NOMESCO Finland

Peritoneal dialysis

10.1

34.5

M35.5

ICD-10 Finland

Multifocal fibrosclerosis

+∞

34.4

44698

ICD-8 Finland

Polyarteritis nodosa and allied conditions, Other

+∞

34.4

A46

ICD-10 Finland

Erysipelas

1.9

34.1

482

2726

UJF32

NOMESCO Finland

Coloscopy

1.7

34.0

815

5399

A10AB05

ATC

insulin aspart; parenteral

2.4

34.0

261

1169

C08CA05

ATC

nifedipine; systemic

2.5

33.9

226

949

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.9

33.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.4

33.7

123

371

TAB00

NOMESCO Finland

Lumbar puncture

3.0

33.7

156

543

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.3

33.6

263

1188

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

33.4

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.4

33.4

C07AB07

ATC

bisoprolol; oral

1.6

33.2

1515

11784

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

330.9

32.9

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

32.9

620

3832

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.0

32.7

153

536

UDM02

NOMESCO Finland

Sinoscopy

4.0

32.3

234

M30.8

ICD-10 Finland

Other conditions related to polyarteritis nodosa

+∞

32.3

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.9

32.1

258

WX892

NOMESCO Finland

Monitored bed care

2.3

31.9

271

1266

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.6

31.8

198

804

H15.1

ICD-10 Finland

Episcleritis

5.4

31.7

116

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

10.4

31.6

N02BE01

ATC

paracetamol; systemic, rectal

2.0

31.6

2531

22677

M32.0

ICD-10 Finland

Drug-induced systemic lupus erythematosus

+∞

31.3

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

31.3

151

538

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.5

31.2

215

916

J01CA04

ATC

amoxicillin; systemic

1.7

31.2

2221

19136

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.1

30.8

135

455

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

3.0

30.8

136

461

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.6

30.6

1290

9781

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

30.4

323

1648

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

30.3

118

371

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

30.3

497

2939

M05BA06

ATC

ibandronic acid; systemic

3.6

30.1

102

293

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

30.0

229

1022

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

29.9

567

3499

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

29.9

445

2550

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.4

29.8

178

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

29.8

1139

8426

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.3

29.7

113

350

V03AE03

ATC

lanthanum carbonate; oral

10.8

29.6

M05BB03

ATC

alendronic acid and colecalciferol; oral

3.3

29.4

111

342

NHQ40

NOMESCO Finland

Amputation of toe

4.3

29.3

176

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

29.3

1122

8291

4462A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Hypersensitivity angiitis

+∞

29.2

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

29.2

250

1171

H47.1

ICD-10 Finland

Papilloedema, unspecified

8.5

28.8

J05AB11

ATC

valaciclovir; oral

1.9

28.6

424

2424

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.2

28.6

268

1302

J01AA02

ATC

doxycycline; systemic

1.7

28.3

2168

18722

M79.6

ICD-10 Finland

Pain in limb

1.6

28.3

1154

8633

Z2221

NOMESCO Finland

Medical doctor

1.6

28.0

769

5234

1AA01, ,

NOMESCO Finland

64.7

28.0

R4110

NOMESCO Finland

Physiotherapy

1.6

27.9

802

5520

R04.2

ICD-10 Finland

Haemoptysis

2.9

27.9

133

471

A03

ICPC

Fever

1.9

27.8

411

2348

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

27.8

278

1385

3025

Kela drug reimbursment

Calcium carbonate

8.0

27.3

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

27.2

497

3027

N08.5*M30.0

ICD-10 Finland

Glomerular disorders in polyarteritis nodosa

+∞

27.1

4465A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Giant cell arteritis

+∞

27.1

R53

ICD-10 Finland

Malaise and fatigue

1.7

26.7

688

4599

J05AB01

ATC

aciclovir; systemic

1.7

26.6

620

4037

J01FA06

ATC

roxithromycin; oral

1.5

26.4

1107

8299

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

26.3

318

1697

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

26.0

1063

7918

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.4

25.8

191

840

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

4.9

25.8

115

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.2

25.7

104

335

A02BC03

ATC

lansoprazole; oral

1.6

25.7

840

5944

A07AA02

ATC

nystatin; oral

2.3

25.6

206

939

S97

ICPC

Chronic ulcer skin

2.2

25.6

216

1005

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.9

25.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

25.1

105

345

4464A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Wegener's granulomatosis

+∞

25.0

N085, M318,

ICD-10 Finland

+∞

25.0

ZXD05

NOMESCO Finland

Urgent procedure

1.6

25.0

836

5937

RS221, ,

NOMESCO Finland

4.5

25.0

138

ZXA00

NOMESCO Finland

Right side

1.6

24.9

800

5628

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.2

24.9

213

996

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

24.8

584

3806

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

24.8

135

513

L95

ICPC

Osteoporosis

2.6

24.7

152

614

ZXA10

NOMESCO Finland

Bilateral

1.7

24.5

565

3662

A01

ICPC

Pain general/multiple sites

2.0

24.4

286

1507

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

24.0

230

1126

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

23.8

257

1315

5BA08, ,

NOMESCO Finland

7.0

23.8

321

Kela drug reimbursment

Paricalcitol and cinacalcet

6.1

23.7

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

23.5

903

6597

B02.9

ICD-10 Finland

Zoster without complication

2.1

23.4

223

1088

G44.2

ICD-10 Finland

Tension-type headache

1.8

23.3

372

2169

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

6.1

23.3

ZXE00

NOMESCO Finland

One hour or less

1.5

23.3

1055

7983

A02BC05

ATC

esomeprazole; systemic

1.5

23.3

1113

8516

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

23.2

1844

15633

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

23.1

459

2853

N05CF01

ATC

zopiclone; oral

1.5

23.1

942

6968

R03AC02

ATC

salbutamol; inhalant

1.5

23.0

1445

11674

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

22.9

1198

9323

M34.1

ICD-10 Finland

CR(E)ST syndrome

+∞

22.9

M81.4

ICD-10 Finland

Drug-induced osteoporosis

7.4

22.9

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.4

22.8

165

719

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.7

22.7

481

3040

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.5

22.7

142

578

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

4.7

22.7

112

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.6

22.6

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.3

22.5

181

825

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

22.5

714

4991

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

22.3

569

3772

L17

ICPC

Foot/toe symptom/complaint

1.5

22.3

797

5718

H34.1

ICD-10 Finland

Central retinal artery occlusion

6.3

22.3

B01AA03

ATC

warfarin; systemic

1.6

22.2

613

4143

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

3.3

22.2

255

R52.9

ICD-10 Finland

Pain, unspecified

1.9

22.1

279

1507

S18

ICPC

Laceration/cut

1.5

22.1

1278

10125

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.9

22.1

107

382

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

22.1

222

1106

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

22.0

102

356

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.3

21.9

174

789

UKC02

NOMESCO Finland

Cystoscopy

1.7

21.8

478

3046

N03AX12

ATC

[U] gabapentin; oral

1.7

21.8

469

2974

3AC01, ,

NOMESCO Finland

5.0

21.8

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

21.8

942

7033

M79.1

ICD-10 Finland

Myalgia

1.8

21.7

374

2228

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.8

21.7

172

M25.5

ICD-10 Finland

Pain in joint

1.5

21.7

806

5827

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.4

21.6

229

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

21.5

289

1594

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.4

21.5

240

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

21.4

293

1626

TNG10

NOMESCO Finland

Puncture of knee

4.9

21.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.8

21.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.5

21.2

132

536

XCK00

NOMESCO Finland

Perimetry

2.1

21.2

207

1020

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.9

21.0

102

365

R60.0

ICD-10 Finland

Localized oedema

1.8

20.9

379

2290

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

5.9

20.9

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

20.9

332

1931

J02AC01

ATC

fluconazole; systemic

1.5

20.7

982

7454

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

20.7

805

5868

UJF92

NOMESCO Finland

Capsular endoscopy

3.4

20.4

223

PG1AE

NOMESCO Finland

Ultrasound examination of artery not elsewher classified

7.0

20.4

M13.0

ICD-10 Finland

Polyarthritis, unspecified

4.6

20.3

106

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.8

20.3

334

1963

WX002

NOMESCO Finland

Sedation and analgesia

1.6

20.1

570

3866

I73.0

ICD-10 Finland

Raynaud syndrome

4.5

20.1

111

WZC30

NOMESCO Finland

Teaching

1.7

20.0

453

2906

N19

ICD-10 Finland

Unspecified kidney failure

2.5

20.0

133

557

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.3

19.9

120

R05

ICD-10 Finland

Cough

1.6

19.7

575

3928

Z3226

NOMESCO Finland

Physiotherapist

1.6

19.6

515

3430

E0000UV, ,

ATC

1.5

19.5

1083

8454

R51.81

ICD-10 Finland

Facial pain NOS

3.1

19.4

271

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

19.4

191

R04.0

ICD-10 Finland

Epistaxis

1.9

19.3

244

1318

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.9

19.3

326

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.2

947

7219

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

19.2

172

820

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

5.6

19.1

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

19.1

459

2989

JN4BD

NOMESCO Finland

Extensive body CT

1.8

19.0

318

1876

R51

ICD-10 Finland

Headache

2.3

18.9

144

641

7100A

ICD-9 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

+∞

18.8

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

18.7

711

5137

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

7.7

18.7

R02

ICPC

Shortness of breath/dyspnoea

1.7

18.5

374

2325

R01AD08

ATC

fluticasone; nasal

1.5

18.5

700

5052

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.3

18.5

222

H53.2

ICD-10 Finland

Diplopia

2.5

18.3

112

452

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

7.5

18.2

Z71.8

ICD-10 Finland

Other specified counselling

1.5

18.2

757

5566

318

Kela drug reimbursment

Teriparatide

6.0

18.2

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

7.2

18.2

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

18.2

454

2980

H05AA02

ATC

teriparatide; parenteral

6.1

18.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

18.1

343

2097

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

6.3

18.0

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.4

17.9

196

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

6.7

17.9

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

7.3

17.8

N17.8

ICD-10 Finland

Other acute renal failure

3.8

17.8

140

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

17.7

533

3655

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

17.7

219

1174

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

6.2

17.7

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.5

17.6

110

448

NXL00

NOMESCO Finland

Biopsy of muscle

14.6

17.6

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

17.6

210

1113

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.3

17.5

137

617

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

17.4

136

613

B01AC04

ATC

clopidogrel; oral

1.6

17.3

499

3386

R4190

NOMESCO Finland

Nutritional therapy

2.6

17.2

103

411

ZXA05

NOMESCO Finland

Left side

1.5

17.2

711

5215

L28

ICPC

Limited function/disability (L)

1.5

17.1

539

3734

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

17.1

193

1003

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

17.1

666

4826

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

3.7

16.9

145

A04

ICPC

Weakness/tiredness general

1.6

16.9

411

2680

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

5.4

16.8

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

14.1

16.8

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

16.8

173

870

J01FA10

ATC

azithromycin; systemic

1.4

16.8

1387

11520

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

16.7

106

M31.2

ICD-10 Finland

Lethal midline granuloma

+∞

16.7

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.5

16.6

166

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

171.0

16.5

4AC07, ,

NOMESCO Finland

171.0

16.5

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

27.7

16.5

H72.0

ICD-10 Finland

Central perforation of tympanic membrane

3.2

16.5

212

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

16.4

293

1758

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

16.4

211

1145

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

16.4

1001

7880

L95.8

ICD-10 Finland

Other vasculitis limited to skin

12.2

16.3

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

16.3

283

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

16.3

505

3482

J47

ICD-10 Finland

Bronchiectasis

3.0

16.2

251

R81

ICPC

Pneumonia

2.4

16.2

109

460

A12AA12

ATC

[U] calcium acetate

16.8

16.1

M05.2

ICD-10 Finland

Rheumatoid vasculitis

47.8

16.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

15.9

123

552

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

4.6

15.9

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

12.3

15.8

M04AA01

ATC

allopurinol; systemic

1.6

15.8

387

2523

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.5

15.8

102

422

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

15.8

181

945

J01CF05

ATC

flucloxacillin; systemic

2.0

15.7

169

864

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.9

15.6

116

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

15.6

222

1245

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

15.6

320

1996

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.8

15.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

15.4

442

2991

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

15.4

158

793

N25.0

ICD-10 Finland

Renal osteodystrophy

12.4

15.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

15.3

224

1267

J45.8

ICD-10 Finland

Mixed asthma

2.5

15.3

392

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

15.3

347

2219

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

15.2

392

2586

A01AB10

ATC

natamycin; local oral

2.5

15.1

371

R55

ICD-10 Finland

Syncope and collapse

1.7

15.0

320

2013

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

5.1

15.0

R01AD09

ATC

mometasone; nasal

1.4

15.0

1079

8700

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

15.0

361

2342

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.3

15.0

111

489

ED1AA

NOMESCO Finland

Mandibular X-ray examination

5.4

14.9

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

14.9

729

5497

DC1AD

NOMESCO Finland

Temporalbone CT

4.1

14.9

C08CA02

ATC

felodipine; oral

1.7

14.9

291

1790

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

14.9

157

796

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

14.9

137

660

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

14.9

173

908

6BA02, ,

NOMESCO Finland

15.1

14.9

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

3.2

14.8

179

SPAT1263

SPAT

Sampling

1.4

14.7

1095

8871

M10.9

ICD-10 Finland

Gout, unspecified

1.9

14.7

204

1135

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.5

14.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

14.7

641

4731

D68.8

ICD-10 Finland

Other specified coagulation defects

4.1

14.6

C10AA05

ATC

atorvastatin; oral

1.4

14.6

1177

9657

L93.0

ICD-10 Finland

Discoid lupus erythematosus

6.4

14.6

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.7

14.5

317

2007

RD210, ,

NOMESCO Finland

3.3

14.5

161

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

14.5

343

2216

H05BX01

ATC

cinacalcet; oral

4.8

14.5

H53.4

ICD-10 Finland

Visual field defects

2.8

14.4

251

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.6

14.3

PD5AD

NOMESCO Finland

CT of aorta

2.7

14.3

275

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

14.3

271

1654

ZY010

NOMESCO Finland

Hospital outpatient

2.2

14.2

118

546

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

13.4

14.2

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

3.0

14.1

200

UDC00

NOMESCO Finland

Ear microscopy

1.8

14.1

200

1121

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.1

14.1

128

614

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

14.1

470

3284

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

14.0

354

R01AD12

ATC

fluticasone furoate; nasal

1.4

14.0

696

5255

RS222, ,

NOMESCO Finland

3.8

14.0

112

M79.7

ICD-10 Finland

Fibromyalgia

2.5

13.9

337

205

Kela drug reimbursment

Chronic hypertension

1.4

13.9

815

6332

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

13.9

187

1030

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

13.9

378

2524

B01AF02

ATC

apixaban; oral

1.6

13.8

385

2584

1CX01, ,

NOMESCO Finland

17.6

13.8

B01AB10

ATC

tinzaparin; parenteral

1.7

13.8

272

1676

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

20.1

13.8

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

13.8

327

2114

XX9XW, ,

NOMESCO Finland

5.3

13.7

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.8

13.7

236

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.9

13.7

100

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

13.7

197

1109

R03BB04

ATC

tiotropium bromide; inhalant

1.7

13.6

291

1832

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.2

13.6

115

536

KBV00

NOMESCO Finland

Insertion of stent into ureter

5.0

13.6

C08CA13

ATC

lercanidipine; oral

1.5

13.6

422

2903

G05.8*M32.1

ICD-10 Finland

Encephalitis in systemic lupus erythematosus

+∞

13.5

EB1WA, ,

NOMESCO Finland

5.5

13.5

R80

ICD-10 Finland

Isolated proteinuria

4.7

13.5

R42

ICD-10 Finland

Dizziness and giddiness

1.4

13.5

629

4688

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.5

13.4

343

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

13.4

193

1088

J01DA01

ATC

[U] cefalexin

1.3

13.3

1596

13844

R03DC03

ATC

montelukast; oral

1.5

13.3

397

2707

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.2

13.2

G50.1

ICD-10 Finland

Atypical facial pain

3.0

13.2

192

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

13.1

471

3336

J01FA09

ATC

clarithromycin; systemic

1.4

13.1

747

5765

R05

ICPC

Cough

1.4

13.1

601

4463

XF402

NOMESCO Finland

ECG with work load test

1.6

13.1

296

1891

B07.9

ICD-10 Finland

Verruca simplex

2.4

13.0

391

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

13.0

189

1068

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

22.6

12.9

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

3.2

12.9

158

M05BA01

ATC

etidronic acid; systemic

4.9

12.8

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

11.6

12.8

D07AC01

ATC

betamethasone; topical

1.4

12.8

908

7263

K65.0

ICD-10 Finland

Acute peritonitis

3.6

12.7

115

SPAT1301

SPAT

No procedures

1.4

12.7

836

6605

A01AB09

ATC

miconazole; local oral

1.7

12.7

240

1463

J20

ICD-10 Finland

Acute bronchitis

1.7

12.6

254

1573

H65.0

ICD-10 Finland

Acute serous otitis media

3.3

12.6

145

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.6

905

7249

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

12.6

363

2455

A02BA02

ATC

ranitidine; systemic

1.5

12.5

533

3901

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

12.5

160

868

ZX100

NOMESCO Finland

Oral

3.2

12.5

156

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

130.6

12.4

D59.3

ICD-10 Finland

Haemolytic-uraemic syndrome

130.6

12.4

B01AB05

ATC

enoxaparin; parenteral

1.4

12.3

855

6803

J32.4

ICD-10 Finland

Chronic pansinusitis

3.3

12.3

137

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

12.3

128

647

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

12.3

115

559

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

12.2

100

461

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.4

12.1

360

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

12.1

456

R11

ICD-10 Finland

Nausea and vomiting

1.7

12.1

231

1412

R31

ICD-10 Finland

Unspecified haematuria

1.6

12.0

277

1775

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

12.0

325

SPAT1255

SPAT

Intravenous administration of medicine

1.8

12.0

189

1094

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.2

12.0

H15.0

ICD-10 Finland

Scleritis

9.3

12.0

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

12.0

939

7610

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

11.9

339

2283

L99

ICPC

Musculoskeletal disease other

2.7

11.9

226

N06AA09

ATC

amitriptyline; systemic

1.6

11.9

264

1677

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

11.9

230

1410

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

4.6

11.9

JN6JR

NOMESCO Finland

Extensive PET-CT of whole body metabolism (crown to foot)

46.9

11.9

EBA10

NOMESCO Finland

Operative extraction of tooth

1.7

11.8

245

1529

N02BF01

ATC

gabapentin; oral

1.7

11.8

211

1266

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

11.8

340

N30.0

ICD-10 Finland

Acute cystitis

1.5

11.8

431

3061

SPAT1262

SPAT

Handing over of treatment supplies

1.5

11.8

471

3405

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

11.7

188

1093

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.9

11.7

184

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

11.6

720

5618

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

11.6

226

1388

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

19.0

11.6

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.6

11.6

108

XKD00

NOMESCO Finland

Uroflowmetry

1.5

11.5

397

2784

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.1

11.5

148

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

11.5

162

906

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

11.5

126

649

L18

ICPC

Muscle pain

2.1

11.5

108

526

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

5.0

11.5

M33.1

ICD-10 Finland

Other dermatomyositis

+∞

11.5

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

+∞

11.5

N03.7

ICD-10 Finland

Chronic nephritic syndrome, diffuse crescentic glomerulonephritis

120.5

11.4

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.2

11.4

134

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

11.3

204

SPAT1254

SPAT

Administration of medicine

1.5

11.3

403

2847

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

11.3

626

4794

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

9.6

11.2

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.6

11.2

239

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

11.2

150

826

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

11.2

179

1041

C09CA01

ATC

losartan; oral

1.4

11.1

699

5460

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.8

11.1

189

G62.8

ICD-10 Finland

Other specified polyneuropathies

3.9

11.1

H26.4

ICD-10 Finland

After-cataract

1.6

11.1

309

2072

M54.4

ICD-10 Finland

Lumbago with sciatica

1.5

11.0

416

2970

N02AA05

ATC

oxycodone; systemic

1.4

11.0

501

3704

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.3

11.0

D72.1

ICD-10 Finland

Eosinophilia

5.7

11.0

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.6

10.9

254

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.5

10.9

260

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.8

10.9

191

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

10.8

347

WVA20

NOMESCO Finland

Medicine administration

2.4

10.8

310

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

5.1

10.8

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

10.7

263

1712

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.7

845

6831

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.4

10.7

287

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.3

10.7

124

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.0

10.7

150

E000006, ,

ATC

1.8

10.6

175

1026

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.4

10.6

300

R52.2

ICD-10 Finland

Other chronic pain

2.1

10.6

474

NFQ20

NOMESCO Finland

Amputation of femur

3.8

10.6

NGQ20

NOMESCO Finland

Amputation of lower leg

4.4

10.5

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.0

10.5

109

551

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

10.5

158

903

F29

ICPC

Eye symptom/complaint other

1.6

10.5

228

1441

4AC0X, ,

NOMESCO Finland

+∞

10.4

R13

ICD-10 Finland

Dysphagia

1.7

10.4

187

1125

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

10.4

251

1628

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

32.6

10.3

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

10.3

271

1792

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

5.2

10.3

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.2

10.3

122

B34.9

ICD-10 Finland

Viral infection, unspecified

2.5

10.3

262

R4120

NOMESCO Finland

Occupational therapy

1.8

10.3

164

954

C02AC05

ATC

moxonidine; oral

1.9

10.2

137

755

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

4.0

10.2

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

10.2

635

4944

C09AA02

ATC

enalapril; systemic

1.4

10.2

540

4096

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.2

10.2

402

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

10.1

396

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.8

10.1

182

CS494

NOMESCO Finland

Other visual field testing

2.3

10.1

345

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

10.1

172

1019

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

10.1

162

944

R03BA05

ATC

fluticasone; inhalant

1.4

10.1

433

3167

A07AA09

ATC

vancomycin; oral

3.0

10.0

150

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

10.0

411

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.8

10.0

148

841

NH4AE

NOMESCO Finland

Achilles tendon ultrasound examination

4.8

10.0

L04AK01

ATC

leflunomide; oral

4.8

10.0

XF404

NOMESCO Finland

Ambulatory ECG

1.6

10.0

237

1530

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

3.3

10.0

114

SPAT1153

SPAT

Removal of sutures

1.3

10.0

841

6848

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

10.0

120

639

N08.2*D69.0

ICD-10 Finland

Glomerular disorders in Henoch(-Schönlein) purpura

40.2

10.0

73410

ICD-8 Finland

Diffuse diseases of connective tissue, Systemic lupus erythematosus

40.2

10.0

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

10.0

360

H04.3

ICD-10 Finland

Acute and unspecified inflammation of lacrimal passages

4.2

9.9

45100

ICD-8 Finland

Phlebitis and thrombophlebitis, Of lower extremities

3.5

9.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

9.9

454

H25.8

ICD-10 Finland

Other senile cataract

1.5

9.9

336

2349

B01AB04

ATC

dalteparin; parenteral

1.8

9.8

138

773

R74

ICPC

Upper respiratory infection acute

1.4

9.8

626

4891

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

3.5

9.8

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

4.0

9.8

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

9.7

145

826

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

3.5

9.7

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.2

9.7

121

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

9.7

485

3639

SPAT1260

SPAT

Consultation of another employee

1.4

9.7

446

3299

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.5

9.7

227

C09CA06

ATC

candesartan; oral

1.4

9.7

579

4475

H34.2

ICD-10 Finland

Other retinal artery occlusions

4.1

9.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

9.7

973

8110

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

9.7

101

512

L20

ICPC

Joint symptom/complaint NOS

2.1

9.7

444

WW500

NOMESCO Finland

Blood transfusion

2.0

9.7

109

568

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

9.6

309

2133

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.8

9.6

165

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

9.6

533

4073

B00.9

ICD-10 Finland

Herpesviral infection, unspecified

5.0

9.6

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.9

9.5

117

627

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.5

9.5

247

I20.09

ICD-10 Finland

Unstable angina

1.7

9.5

165

982

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

9.5

495

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

9.5

371

2664

G45.3

ICD-10 Finland

Amaurosis fugax

2.4

9.5

248

N08.2*D59.3

ICD-10 Finland

Glomerular disorders in haemolytic-uraemic syndrome

100.4

9.4

N05.9

ICD-10 Finland

Unspecified nephritic syndrome, unspecified

17.6

9.4

D638, N188,

ICD-10 Finland

17.6

9.4

4467A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Takayasu's disease

+∞

9.4

N085M, ,

ICD-10 Finland

+∞

9.4

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

9.3

383

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

9.3

353

2518

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

9.3

221

1426

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

9.3

1701

15269

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

3.0

9.3

135

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

3.2

9.3

109

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.5

9.3

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

9.3

164

982

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

9.3

331

2335

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

3.7

9.3

SPAT1325

SPAT

Vaccination

1.3

9.2

892

7389

S86.0

ICD-10 Finland

Injury of Achilles tendon

2.3

9.2

295

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

9.2

205

1305

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

3.9

9.1

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

9.1

106

559

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.5

9.0

211

J04AB02

ATC

rifampicin; systemic

3.0

9.0

127

H46

ICD-10 Finland

Optic neuritis

4.1

9.0

PE1AT

NOMESCO Finland

Femoral artery PTA

2.8

9.0

149

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

8.9

210

1353

PD5DG

NOMESCO Finland

Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

18.6

8.9

I77.9

ICD-10 Finland

Disorder of arteries and arterioles, unspecified

18.6

8.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

8.9

327

2318

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.9

8.9

144

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

8.9

1542

13715

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

8.9

240

1596

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

8.9

140

812

XPX04

NOMESCO Finland

Angioscopy

12.6

8.9

L95.0

ICD-10 Finland

Livedoid vasculitis

12.6

8.9

K07.60

ICD-10 Finland

Snapping jaw

1.9

8.9

104

550

R06AE07

ATC

cetirizine; oral

1.3

8.8

1032

8746

M54.5

ICD-10 Finland

Low back pain

1.3

8.8

841

6946

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

10.7

8.8

M35.7

ICD-10 Finland

Hypermobility syndrome

10.7

8.8

M70.2

ICD-10 Finland

Olecranon bursitis

2.1

8.8

413

M48.0

ICD-10 Finland

Spinal stenosis

1.4

8.8

340

2436

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

8.8

1700

15315

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.0

8.8

482

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.9

8.7

140

S29

ICPC

Skin symptom/complaint other

1.4

8.7

471

3576

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

8.7

104

553

I15.0

ICD-10 Finland

Renovascular hypertension

4.1

8.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

8.7

146

862

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

8.7

124

698

K12.00

ICD-10 Finland

Recurrent oral aphthae

3.1

8.7

119

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

50.1

8.7

SBB10

NOMESCO Finland

Dental impressions

1.8

8.7

134

773

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

8.7

134

773

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

7.6

8.6

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

8.6

241

1616

PA6AD

NOMESCO Finland

CT of neck arteries

2.1

8.6

369

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

8.6

255

1731

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

8.6

506

A12BA01

ATC

potassium chloride; oral

1.8

8.5

136

791

E000001, ,

ATC

1.4

8.5

454

3441

I50.0

ICD-10 Finland

Congestive heart failure

1.6

8.5

211

1378

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.5

182

1148

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.7

8.4

D07AB08

ATC

desonide; topical

1.5

8.4

249

1689

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.6

8.4

177

TQW99

NOMESCO Finland

Other minor procedure on skin

1.7

8.4

140

825

WX722

NOMESCO Finland

PEEP

1.8

8.4

120

676

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

8.4

250

1701

N01.7

ICD-10 Finland

Rapidly progressive nephritic syndrome, diffuse crescentic glomerulonephritis

+∞

8.3

4466A

ICD-9 Finland

Polyarteritis nodosa and allied conditions, Thrombotic microangiopathy

+∞

8.3

4AC0L, ,

NOMESCO Finland

+∞

8.3

KH1EE

NOMESCO Finland

Urologic ultrasound examination

8.5

8.3

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

10.8

8.3

R03BA01

ATC

beclometasone; inhalant

1.4

8.3

337

2436

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

8.3

264

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

2.3

8.3

277

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

8.3

653

5249

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.4

8.2

227

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.8

8.2

145

WX402

NOMESCO Finland

General anaesthesia

1.4

8.2

476

3654

M13.8

ICD-10 Finland

Other specified arthritis

3.4

8.2

N00.9

ICD-10 Finland

Acute nephritic syndrome, Unspecified

14.5

8.2

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

8.2

104

565

SAA04

NOMESCO Finland

Special examination of mouth

1.8

8.1

123

705

K02.1

ICD-10 Finland

Caries of dentine

1.3

8.1

1330

11699

H03AA01

ATC

levothyroxine sodium; systemic

1.3

8.1

582

4612

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

4.5

8.1

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

3.1

8.1

103

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

3.2

8.1

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

33.4

8.1

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

8.1

101

546

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

8.1

734

6010

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.8

8.1

PAA99

NOMESCO Finland

Exploration of other arterial branch originating from aortic arch arteries

22.1

8.0

R04.8

ICD-10 Finland

Haemorrhage from other sites in respiratory passages

22.1

8.0

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.9

8.0

125

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

3.1

8.0

109

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.9

8.0

105

577

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

8.0

340

M03BX02

ATC

tizanidine; oral

1.3

8.0

1460

12999

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

7.9

117

666

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

7.9

199

1304

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

4.4

7.9

DPA30

NOMESCO Finland

Sphenotomy

4.0

7.9

N03.1

ICD-10 Finland

Chronic nephritic syndrome, focal and segmental glomerular lesions

13.1

7.9

DJA10

NOMESCO Finland

Biopsy of septum of nose

13.1

7.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

7.8

1054

9052

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

10.8

7.8

XQ800

NOMESCO Finland

Prick test

1.7

7.8

148

905

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

9.4

7.8

L01

ICPC

Neck symptom/complaint

1.4

7.8

352

2594

U14

ICPC

Kidney symptom/complaint

2.5

7.7

185

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.7

7.7

150

J33.0

ICD-10 Finland

Polyp of nasal cavity

2.1

7.7

331

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

7.7

253

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

7.7

104

576

K05.30

ICD-10 Finland

Periodontitis complex

1.4

7.7

333

2432

D638, N189,

ICD-10 Finland

15.1

7.7

Z99.2

ICD-10 Finland

Dependence on renal dialysis

15.1

7.7

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.5

7.7

213

1425

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

7.7

125

732

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.1

7.7

101

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

7.7

197

1296

NK6PA

NOMESCO Finland

Measurement of bone density from one location with X-ray

5.9

7.7

B37.08

ICD-10 Finland

Other candidal stomatitis

3.4

7.7

J01EA01

ATC

trimethoprim; systemic

1.3

7.6

669

5447

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.6

7.6

163

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

8.0

7.6

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

7.6

354

Z00.0

ICD-10 Finland

General medical examination

1.4

7.6

461

3563

A10BH05

ATC

linagliptin; oral

1.7

7.6

141

858

L52

ICD-10 Finland

Erythema nodosum

4.1

7.5

N06AX21

ATC

duloxetine; oral

1.5

7.5

259

1814

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.2

7.5

276

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

7.5

390

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.5

196

1297

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.9

7.4

114

A01AB04

ATC

amphotericin B; local oral

1.7

7.4

127

755

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

3.9

7.4

R33

ICD-10 Finland

Retention of urine

1.5

7.4

201

1339

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

7.4

372

2788

R03BA08

ATC

ciclesonide; inhalant

1.5

7.4

196

1299

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

3.1

7.4

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.2

7.4

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

7.4

178

1155

7901A

ICD-9 Finland

Nonspecific findings on examination of blood, Elevated sedimentation rate

13.4

7.4

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.4

7.4

NG1DA

NOMESCO Finland

X-ray of knees

2.4

7.4

208

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.0

7.3

104

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

7.3

414

3162

G47.3

ICD-10 Finland

Sleep apnoea

1.3

7.3

500

3929

R03BA02

ATC

budesonide; inhalant

1.4

7.3

412

3145

M01AH02

ATC

rofecoxib; oral

1.4

7.3

327

2404

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

+∞

7.3

M31

ICD-10 Finland

Other necrotizing vasculopathies

+∞

7.3

M32

ICD-10 Finland

Systemic lupus erythematosus

+∞

7.3

N00.7

ICD-10 Finland

Acute nephritic syndrome, Diffuse crescentic glomerulonephritis

+∞

7.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

7.3

M35.2

ICD-10 Finland

Behçet disease

+∞

7.3

XG405

NOMESCO Finland

Education on PEF monitoring

2.6

7.3

149

S19

ICPC

Skin injury other

1.8

7.3

543

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

7.3

548

4367

A99

ICPC

Disease/condition unspecnature/site

1.5

7.3

228

1567

U02

ICPC

Urinary frequency/urgency

1.4

7.3

351

2614

C03DA01

ATC

spironolactone; oral

1.4

7.2

318

2330

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.8

7.2

127

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.8

7.2

127

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.2

552

Z01.2

ICD-10 Finland

Dental examination

1.3

7.2

998

8579

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.5

7.2

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

3.9

7.2

H92.0

ICD-10 Finland

Otalgia

1.7

7.2

125

748

A06AD11

ATC

lactulose; oral

1.4

7.1

397

3024

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.1

7.1

308

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

7.1

236

1640

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.0

7.1

397

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

7.1

471

3684

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.5

7.1

175

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

7.1

736

6116

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

7.1

474

3715

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

7.0

1269

11221

A41.8

ICD-10 Finland

Other specified sepsis

2.3

7.0

238

207

Kela drug reimbursment

Chronic arrhythmias

1.3

7.0

439

3405

C10AA01

ATC

simvastatin; oral

1.2

7.0

1167

10229

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.1

7.0

N02BF02

ATC

pregabalin; oral

1.7

7.0

129

783

D69.9

ICD-10 Finland

Haemorrhagic condition, unspecified

4.2

7.0

WX872

NOMESCO Finland

Intensive care

1.7

7.0

126

760

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

7.0

480

3773

R07.0

ICD-10 Finland

Pain in throat

1.7

7.0

130

791

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.4

7.0

268

1916

E000002, ,

ATC

1.5

7.0

228

1580

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

3.9

7.0

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

6.9

153

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.9

662

5440

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.3

6.9

214

DHB10

NOMESCO Finland

Excision of lesion of internal nose

6.3

6.9

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

6.9

494

N91.1

ICD-10 Finland

Secondary amenorrhoea

3.7

6.9

N05CD07

ATC

temazepam; oral

1.4

6.9

314

2314

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.1

6.9

CA1DG

NOMESCO Finland

Eye and orbita very extensive MRI examination with high intensity magnet

13.8

6.9

J38.6

ICD-10 Finland

Stenosis of larynx

13.8

6.9

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.1

6.9

306

A11

ICPC

Chest pain NOS

1.5

6.9

205

1395

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

3.6

6.9

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.8

205

1396

ZZA00

NOMESCO Finland

Split skin graft

1.9

6.8

424

SPAT1310

SPAT

Counselling related to known health issue

1.3

6.8

772

6473

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

6.8

151

960

AN1

Coronary angiography

1.4

6.8

294

2146

104

Kela drug reimbursment

Thyroid insufficiency

1.5

6.8

181

1202

DM1DG

NOMESCO Finland

Paranasal sinuses and face area very extensive MRI examination with high intensity magnet

9.3

6.8

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

6.8

111

653

I67.7

ICD-10 Finland

Cerebral arteritis, not elsewhere classified

40.1

6.8

D07AD01

ATC

clobetasol; topical

1.4

6.8

383

2926

J32.3

ICD-10 Finland

Chronic sphenoidal sinusitis

5.7

6.7

K92.1

ICD-10 Finland

Melaena

1.6

6.7

139

869

TK830

NOMESCO Finland

Ultrafiltration

16.7

6.7

5AB14, ,

NOMESCO Finland

16.7

6.7

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

1.9

6.7

448

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.1

6.7

282

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.7

933

8008

H29

ICPC

Ear symptom/complaint other

1.4

6.7

270

1947

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.2

6.7

263

GBA32

NOMESCO Finland

Endoscopic dilatation of trachea

22.6

6.7

H05.0

ICD-10 Finland

Acute inflammation of orbit

22.6

6.7

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.2

6.7

237

L60.0

ICD-10 Finland

Ingrowing nail

1.7

6.7

109

641

C09AA05

ATC

ramipril; oral

1.3

6.7

666

5501

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.9

6.7

407

J01FA01

ATC

erythromycin; systemic

1.4

6.6

269

1943

RS121, ,

NOMESCO Finland

3.7

6.6

R2110

NOMESCO Finland

Giving the first information

1.6

6.6

142

897

R03AC12

ATC

salmeterol; inhalant

1.7

6.6

115

688

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.6

6.6

137

858

L88

ICD-10 Finland

Pyoderma gangrenosum

7.8

6.6

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

2.4

6.6

175

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

5.9

6.6

K06.18

ICD-10 Finland

Another gingival hyperplasia

5.9

6.6

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

5.5

6.6

X58

ICD-10 Finland

Exposure to other specified factors

1.4

6.6

296

2177

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

6.6

532

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.1

6.6

265

TK824

NOMESCO Finland

Replacement of peritoneal dialysis catheter extension tube

8.7

6.5

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.2

6.5

252

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.6

6.5

168

1107

K11.70

ICD-10 Finland

Hypoptyalism

3.8

6.5

D01

ICPC

Abdominal pain/cramps general

1.4

6.5

250

1788

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

6.5

112

WX610

NOMESCO Finland

Patient controlled analgesia

3.7

6.5

SDA03

NOMESCO Finland

Periodontal treatment

1.2

6.5

855

7293

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.5

471

3733

A08

ICPC

Swelling

1.6

6.4

136

856

GX1K5

NOMESCO Finland

Diffusion capacity

3.9

6.4

C07AG02

ATC

carvedilol; oral

1.6

6.4

157

1023

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

70.0

6.4

WX213

NOMESCO Finland

Lower leg blockade

3.2

6.4

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.8

6.4

107

L29

ICPC

Musculoskeletal sympt/complt other

1.5

6.4

200

1374

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

6.4

175

1169

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.1

6.4

261

R01AD01

ATC

beclometasone; nasal

1.4

6.4

340

2571

N05.8

ICD-10 Finland

Unspecified nephritic syndrome, other

14.3

6.4

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.4

6.4

184

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

6.4

166

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

4.1

6.4

SBA00

NOMESCO Finland

Microbiological examinations

2.1

6.3

289

XQ848

NOMESCO Finland

Dermatological photography

1.9

6.3

379

D07AC13

ATC

mometasone; topical

1.3

6.3

664

5514

X57

ICD-10 Finland

Unspecified privation

2.1

6.3

256

XX3ZW, ,

NOMESCO Finland

11.0

6.3

RT271, ,

NOMESCO Finland

11.0

6.3

H16.0

ICD-10 Finland

Corneal ulcer

1.7

6.3

104

614

C07AB02

ATC

metoprolol; systemic

1.3

6.3

539

4366

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.8

6.3

103

7250A

ICD-9 Finland

Polymyalgia rheumatica[POLYMYALGIA RHEUMATICA]

+∞

6.3

N00.8

ICD-10 Finland

Acute nephritic syndrome, Other

+∞

6.3

G73.7*M32.1

ICD-10 Finland

Myopathy in systemic lupus erythematosus

+∞

6.3

M34.0

ICD-10 Finland

Progressive systemic sclerosis

+∞

6.3

N16.4*M32.1

ICD-10 Finland

Renal tubulo-interstitial disorders in systemic lupus erythematosus

+∞

6.3

XQ860

NOMESCO Finland

Laser Doppler measurement/scan of capillary perfusion

+∞

6.3

N085, M319,

ICD-10 Finland

+∞

6.3

44620

ICD-8 Finland

Polyarteritis nodosa and allied conditions, Other hypersensitivity angiitis

+∞

6.3

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.0

6.2

325

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.2

598

4911

J01DA06

ATC

[U] cefuroxime

1.4

6.2

320

2407

RS220, ,

NOMESCO Finland

2.6

6.2

132

K57.2

ICD-10 Finland

Diverticular disease of large intestine with perforation and abscess

2.2

6.2

225

M01AH03

ATC

valdecoxib; oral

1.6

6.2

142

912

F01

ICPC

Eye pain

2.0

6.2

312

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

6.2

587

4813

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

6.2

326

WX882

NOMESCO Finland

High dependency care

2.0

6.2

347

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.1

6.2

J01XX08

ATC

linezolid; systemic

3.4

6.1

J98.1

ICD-10 Finland

Pulmonary collapse

3.3

6.1

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

6.1

369

M86.8

ICD-10 Finland

Other osteomyelitis

7.7

6.1

K05.1

ICD-10 Finland

Chronic gingivitis

1.6

6.1

141

907

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.1

6.1

246

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.0

6.1

H53.8

ICD-10 Finland

Other visual disturbances

2.5

6.1

139

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

6.1

341

2599

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

6.1

320

2417

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.1

6.1

267

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

2.4

6.1

170

A28

ICPC

Limited function/disability NOS

1.3

6.1

474

3791

DPA20

NOMESCO Finland

Trephine of frontal sinus

8.6

6.0

R96

ICPC

Asthma

1.4

6.0

226

1609

M79.3

ICD-10 Finland

Panniculitis, unspecified

6.7

6.0

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

6.7

6.0

PFP99

NOMESCO Finland

Percutaneous plastic repair of artery of lower leg

10.0

6.0

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.0

6.0

281

A03FA02

ATC

cisapride; oral, rectal

1.5

6.0

186

1276

L08

ICPC

Shoulder symptom/complaint

1.3

6.0

508

4103

R06.2

ICD-10 Finland

Wheezing

1.7

6.0

554

J43.9

ICD-10 Finland

Emphysema, unspecified

2.3

6.0

183

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

5.2

6.0

J37.0

ICD-10 Finland

Chronic laryngitis

1.8

6.0

429

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019198) Lymphocytes [#/volume] in Blood

2230

11685

5.18

317.62

15.2

5.5

1.77

1.92

e9/l

3.30

2098

10225

(3013115) Eosinophils [#/volume] in Blood

2241

11804

5.21

316.51

15.7

5.6

0.17

0.19

e9/l

12.25

2095

10225

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

415

528

9.03

312.20

2.9

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

423

332

14.79

307.65

5.2

1.1

—

(3001604) Monocytes [#/volume] in Blood

2215

11385

5.25

307.65

15.1

5.4

0.64

0.60

e9/l

10.19

2063

9738

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1107

864

20.32

307.65

6.4

1.2

22.06

7.97

u/ml

—

260

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

531

508

12.62

307.65

2.6

1.2

0.24

0.25

g/l

0.73

506

479

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

823

667

16.94

307.65

3.5

1.4

313.61

236.52

titre

0.27

122

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

535

529

12.22

307.65

2.6

1.2

1.22

1.21

g/l

0.16

511

497

(3006315) Basophils [#/volume] in Blood

2216

11409

5.24

307.65

15.2

5.4

0.04

e9/l

0.04

2061

9761

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

501

597

9.97

307.65

1.7

1.5

0.50

10.87

iu/ml

0.55

125

(3037522) Nuclear Ab [Titer] in Serum

1119

2627

6.37

307.65

1.7

1.3

587.97

399.38

titre

2.51

286

518

(40760892) CBC W Ordered Manual Differential panel - Blood

2166

10677

5.29

307.65

15.8

6.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

784

1593

6.41

307.65

4.9

2.7

9.33

10.62

g/l

9.13

748

1444

(3022096) Basophils/100 leukocytes in Blood

2040

10408

4.38

290.27

15.7

5.6

0.61

0.67

6.48

1996

9655

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

260

186

15.28

288.17

3.4

1.1

42.60

—

u/ml

—

(3019069) Monocytes/100 leukocytes in Blood

2077

10766

4.43

288.05

16.1

5.9

8.51

8.76

2.93

2034

10008

(3006504) Eosinophils/100 leukocytes in Blood

2062

10714

4.35

282.92

15.8

5.6

2.28

2.82

27.25

2019

9951

(3018010) Neutrophils/100 leukocytes in Blood

2066

10835

4.30

277.51

15.2

5.6

62.39

57.63

2020

10090

(3002030) Lymphocytes/100 leukocytes in Blood

2083

11016

4.31

275.67

15.9

5.8

23.67

27.21

43.90

2040

10270

(3028026) IgM [Mass/volume] in Serum or Plasma

582

1256

5.57

262.43

2.0

1.9

1.09

1.42

g/l

1.85

543

1135

(3015171) Extractable nuclear Ab [Units/volume] in Serum

414

681

6.94

246.70

1.4

1.2

0.55

0.67

u/ml

0.13

(3013650) Neutrophils [#/volume] in Blood by Automated count

2276

13447

4.44

241.72

17.7

8.7

4.93

4.14

e9/l

38.97

2126

11662

(3004588) Protein electrophoresis panel - Serum or Plasma

658

1693

4.75

239.56

1.7

2.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

728

2095

4.32

228.39

1.9

1.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

717

2062

4.31

224.84

1.8

2.8

64.44

66.27

g/l

6.98

658

1869

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2125

12395

3.81

219.83

13.6

6.7

1.22

1.21

mmol/l

0.41

1875

10467

(40768446) Kidney Pathology biopsy report

158

23.84

218.76

1.6

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

308

418

8.14

217.68

5.8

5.0

517.80

809.67

iu/ml

0.36

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1828

9791

3.42

215.35

3.3

2.2

80.70

78.63

nmol/l

2.46

1736

8616

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

766

2458

3.89

204.32

1.9

1.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1951

11271

3.32

194.16

11.4

6.0

1.21

mmol/l

0.19

1890

10186

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

253

320

8.58

189.17

3.2

2.8

45798.58

2307.92

u/ml

0.45

(3017181) Myelocytes/100 leukocytes in Blood

647

1949

4.00

187.52

7.4

3.9

0.88

0.00

323

698

(3021879) Hepatitis B virus core Ab [Presence] in Serum

520

1332

4.55

187.48

1.4

—

(3023368) Bacteria identified in Blood by Culture

1411

6925

3.06

184.49

5.9

4.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

808

2861

3.55

183.76

2.0

1.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

690

2220

3.78

181.30

13.8

7.2

11.55

10.41

mmol/l

3.58

676

2116

(3002179) Metamyelocytes/100 leukocytes in Blood

604

1789

4.02

178.63

7.1

3.7

0.46

0.72

3.47

284

606

(3021440) Promyelocytes/100 leukocytes in Blood

615

1848

3.97

178.19

7.6

3.9

0.05

0.11

2.05

291

601

(3003458) Phosphate [Moles/volume] in Serum or Plasma

863

3245

3.38

177.60

13.1

5.6

1.10

1.04

mmol/l

6.63

831

2999

(3024980) IgG subclass 4 [Mass/volume] in Serum

237

301

8.50

176.42

1.7

1.6

0.70

0.79

g/l

0.42

172

236

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

248

338

7.94

173.92

1.5

1.1

1.93

6.98

u/ml

0.48

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

269

414

7.07

169.09

1.5

1.1

5.29

3.93

u/ml

0.30

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

283

462

6.69

168.19

1.5

1.1

35.28

8.39

u/ml

1.18

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

782

2851

3.40

168.10

3.9

4.2

248.64

248.17

u/l

0.02

743

2689

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

270

423

6.95

166.87

1.5

1.1

15.52

4.87

u/ml

1.33

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

170

149

12.07

165.80

1.7

1.1

275.68

132.86

titre

1.00

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

398

913

4.90

163.56

1.7

1.8

33.28

38.59

u/l

6.39

362

795

(3025159) Blasts/100 leukocytes in Blood

570

1740

3.85

160.23

7.9

3.9

0.05

0.25

0.59

241

497

(3036481) Cortisol [Moles/volume] in Serum or Plasma

626

2050

3.63

158.37

2.2

2.1

342.26

377.79

nmol/l

3.13

582

1856

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

842

3315

3.19

158.14

4.5

2.6

21.61

22.21

0.57

738

2824

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

872

3513

3.14

157.30

1.4

1.2

37.02

38.94

iu/ml

0.12

290

1102

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1406

7383

2.79

154.35

2.7

2.1

125.27

224.51

u/l

6.84

1342

6878

(3018418) pH of Serum or Plasma

1406

7388

2.78

154.07

8.3

4.0

7.40

0.33

291

1420

(3013707) Erythrocyte sedimentation rate by Westergren method

2448

17321

3.94

153.77

14.5

3.8

17.64

13.36

mm/h

25.95

2375

15868

(3022948) Iron [Moles/volume] in Serum or Plasma

909

3797

3.05

153.32

4.3

2.5

11.46

12.58

umol/l

5.22

863

3535

(3004789) Transferrin [Mass/volume] in Serum or Plasma

861

3527

3.07

149.87

4.3

2.5

2.16

2.30

g/l

12.02

814

3255

(3018095) Leukocytes [#/volume] in Urine

1524

8469

2.72

147.54

8.8

3.7

63.36

119.98

e6/l

2.84

1247

6083

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

287

545

5.74

145.76

1.7

2.0

11.45

11.78

mg/l

0.24

262

499

(3002582) Erythrocytes [#/volume] in Urine

1380

7333

2.71

145.63

7.4

3.2

33.07

80.78

e6/l

4.08

1208

5668

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

435

1174

4.19

144.51

3.1

1.7

1.84

1.52

g/l

6.44

376

1005

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

826

3368

3.05

144.24

1.3

1.2

9.35

14.22

u/ml

1.20

284

1241

(3035350) Ketones [Presence] in Urine by Test strip

1846

11400

2.76

142.82

7.2

3.9

0.00

estimate

0.06

470

2280

(3000850) Epithelial cells [#/volume] in Urine

1086

5160

2.79

142.30

5.6

2.5

4.04

5.74

e6/l

4.95

1022

4624

(3009261) Glucose [Presence] in Urine by Test strip

1859

11539

2.76

142.04

7.2

3.9

0.00

estimate

1.08

440

2066

(3027135) IgG subclass 1 [Mass/volume] in Serum

168

182

9.75

141.27

1.4

6.03

6.92

g/l

1.45

123

134

(3024139) IgG subclass 3 [Mass/volume] in Serum

168

182

9.75

141.27

1.4

0.34

0.40

g/l

0.92

120

134

(3028192) IgG subclass 2 [Mass/volume] in Serum

168

182

9.75

141.27

1.4

2.48

2.89

g/l

1.46

123

135

(3021601) Nitrite [Presence] in Urine by Test strip

1840

11388

2.74

140.95

9.6

5.2

0.00

estimate

0.50

448

2111

(3037467) Urinalysis macro (dipstick) panel - Urine

2323

16294

3.31

139.51

10.6

4.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

962

4.42

137.99

1.6

2.6

3.79

3.64

g/l

1.32

350

869

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

964

4.41

137.60

1.6

2.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

965

4.40

137.41

1.6

2.6

8.41

7.34

g/l

17.06

350

870

(4062490) Immunoglobulin typing, IgG

166

187

9.36

135.48

1.5

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

576

1967

3.42

134.80

7.8

3.8

117.11

92.67

ng/l

4.33

541

1665

(3030467) Casts [#/volume] in Urine by Automated count

1271

6742

2.60

130.92

7.4

3.1

0.26

0.53

e6/l

7.65

1104

5184

(36304419) Bacteria [Presence] in Urine

1240

6517

2.60

130.00

7.0

3.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

334

802

4.58

128.69

1.7

3.6

5.59

1.59

ratio

0.48

(3034860) Kappa light chains.free [Mass/volume] in Serum

337

827

4.49

126.23

1.8

3.6

50.35

63.65

mg/l

0.74

271

671

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

336

826

4.48

125.55

1.8

3.6

38.74

74.25

mg/l

1.31

273

671

(3027945) Reticulocytes/100 erythrocytes in Blood

721

2920

2.97

125.35

3.7

2.5

1.96

1.81

2.36

669

2563

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

901

4.32

124.78

1.6

2.7

9.64

10.38

g/l

2.04

317

801

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

351

903

4.29

123.55

1.6

2.7

3.61

2.92

g/l

17.41

319

809

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

906

4181

2.71

122.50

2.3

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1711

10720

2.49

119.48

8.2

4.7

33.63

35.07

g/l

21.44

1637

9951

(3015736) pH of Urine

1524

9111

2.45

117.35

6.2

3.6

5.60

5.81

1.12

510

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

367

1013

4.01

117.18

2.1

1.9

1.41

2.11

ug/l

0.65

321

884

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2452

18462

3.35

115.80

15.7

7.5

74.23

79.60

u/l

9.65

2412

17302

(3026782) Osmolality of Urine

1000

4973

2.56

114.71

6.1

2.9

510.38

536.27

mosm/kgh2o

4.14

905

4263

(3007164) IgA [Mass/volume] in Serum or Plasma

870

4050

2.65

114.39

1.8

1.5

2.31

2.54

g/l

2.73

654

2358

(3039162) Centromere protein B Ab [Units/volume] in Serum

152

192

8.31

113.08

1.6

1.1

69.99

60.37

u/ml

—

(3021589) Normoblasts [#/volume] in Blood

1631

10184

2.41

111.96

20.8

9.7

0.00

e9/l

0.26

1438

8263

(3023520) Reticulocytes [#/volume] in Blood

580

2203

3.05

111.91

3.3

2.5

71.52

70.19

e9/l

0.30

420

1675

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

319

826

4.22

110.94

1.9

2.7

0.32

1.22

g/l

5.39

285

713

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

294

718

4.45

110.38

1.7

2.6

0.01

0.02

g/l

0.75

272

659

(40760888) Immunoglobulin light chains.free panel - Serum

264

617

4.61

104.66

1.8

3.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

188

328

6.07

103.77

1.6

1.1

63.48

17.69

u/ml

2.49

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

293

758

4.19

101.77

1.7

2.5

33.51

37.82

g/l

18.27

259

662

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

671

2901

2.72

100.69

2.1

1.7

—

(3037756) Immunofixation for Serum or Plasma

239

532

4.81

100.52

1.4

1.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

266

665

4.31

96.57

1.7

2.6

0.00

g/l

-0.00

245

618

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

659

2890

2.67

95.60

2.2

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

266

673

4.26

95.02

1.7

2.6

0.00

g/l

-0.00

245

618

(3018677) aPTT in Platelet poor plasma by Coagulation assay

793

3822

2.49

94.28

3.0

2.1

28.86

29.93

5.06

771

3700

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1833

12640

2.26

91.49

6.7

6.2

10.24

11.75

umol/l

6.97

1773

11977

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

295

836

3.82

89.96

3.0

2.7

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

823

4153

2.38

87.39

5.9

2.7

1.09

1.21

e6/l

0.12

579

2383

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

22.55

87.26

4.4

1.0

103.73

—

u/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

240

600

4.28

86.94

5.9

3.2

1.74

1.61

mg/l

1.25

225

541

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1486

9550

2.16

86.86

4.5

2.8

184.20

135.16

ug/l

7.12

1389

8721

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

182

366

5.24

86.01

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

140

219

6.67

85.94

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1080

6155

2.22

85.39

3.8

2.7

2093.44

6087.96

umol/l

4.09

978

5304

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1098

6302

2.21

85.26

2.9

2.2

3.19

3.06

mg/l

0.93

963

5340

(3013826) Glucose [Moles/volume] in Serum or Plasma

1980

14310

2.26

84.89

7.5

4.7

6.76

6.80

mmol/l

0.36

1907

13450

(3002032) Base excess in Venous blood by calculation

553

2354

2.67

84.15

8.3

3.5

1.68

2.00

mmol/l

1.42

502

1970

(3012544) pH of Venous blood

563

2437

2.63

82.71

8.3

3.5

7.38

—

(3007853) Bacteria identified in Skin by Aerobe culture

614

2772

2.55

82.68

2.4

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

176

356

5.20

82.59

1.3

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

188

403

4.92

82.47

1.5

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

549

2358

2.65

81.87

8.4

3.5

5.79

5.82

kpa

0.37

539

2289

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

182

384

4.99

81.33

1.8

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

225

563

4.25

81.31

1.6

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

981

5502

2.19

79.55

6.8

3.8

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2116

15910

2.28

79.37

7.6

4.8

4053.77

1771.43

e6/l

0.25

237

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

168

340

5.19

78.75

1.4

1.2

258.12

288.87

u/ml

0.53

110

203

(3000991) Gas panel - Venous blood

493

2045

2.71

78.57

12.3

8.2

—

(40758558) Short blood count panel - Blood

1034

5952

2.16

78.20

12.4

6.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

277

829

3.59

77.61

2.3

355.83

804.12

ug/l

0.97

254

790

(3048929) Epstein Barr virus Ab [Presence] in Serum

212

525

4.28

77.61

1.3

1.2

—

(3042936) Bacteria identified in Isolate by Culture

698

3434

2.37

77.25

2.5

2.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

179

390

4.83

76.96

1.7

1.4

15.83

15.59

u/ml

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

776

4010

2.29

76.45

4.1

3.2

0.82

mmol/l

0.01

729

3737

(3011412) CD3 cells [#/volume] in Blood

124

193

6.67

76.43

2.4

2.0

1.09

1.15

e9/l

0.26

113

177

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

159

321

5.19

74.71

1.6

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

162

343

4.95

72.01

1.8

1.4

121.30

124.00

u/ml

0.07

(40759836) Histone Ab [Presence] in Serum by Immunoblot

115

8.42

71.60

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

115

8.42

71.60

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

115

8.42

71.60

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

9.22

71.28

1.5

1.2

5.25

7.40

u/l

0.68

(3022217) INR in Platelet poor plasma by Coagulation assay

1678

11804

2.03

71.19

20.5

16.8

1.26

1.31

inr

1.16

473

3359

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

117

8.27

70.60

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

117

8.27

70.60

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

117

8.27

70.60

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

161

347

4.86

70.06

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

11.15

69.59

1.1

1.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

741

3892

2.22

69.20

6.3

2.9

2.95

2.52

e6/l

0.50

493

2139

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

214

587

3.86

67.97

1.8

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

148

310

4.98

66.59

1.5

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

109

173

6.51

65.89

1.8

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

367

1441

2.78

64.34

2.6

2.4

20.89

23.61

au/ml

0.11

(3010375) cycloSPORINE [Mass/volume] in Blood

8.92

63.98

25.5

25.8

94.87

117.80

ug/l

1.99

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

204

567

3.80

63.51

1.8

1.5

—

(3042733) HLA Ab [Presence] in Serum

12.41

62.56

6.2

4.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

155

356

4.55

62.34

1.6

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

336

1295

2.81

60.89

1.4

1.3

31.70

52.23

au/ml

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

137

6.98

60.30

1.3

1.1

17.56

5.20

u/ml

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

128

7.23

60.25

2.3

2.1

462.04

537.35

e6/l

0.39

110

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

118

222

5.50

59.89

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

18.07

59.43

5.1

4.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

121

7.39

59.41

2.4

2.1

0.17

0.22

e9/l

1.06

109

(3012516) Albumin [Mass/volume] in Urine

1152

7433

1.92

59.35

6.4

3.2

511.72

286.31

mg/l

0.95

866

4696

(3037121) Protein [Mass/volume] in Urine

252

842

3.19

58.84

5.1

3.0

0.47

0.26

g/l

2.43

155

334

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

211

632

3.53

58.71

1.6

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1174

7701

1.89

56.84

3.5

3.1

1849.43

1589.74

ng/l

0.75

1053

6649

(3009508) Creatinine [Moles/volume] in Urine

1172

7716

1.88

55.82

6.6

3.1

6.72

7.15

mmol/l

3.20

1040

6439

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

165

432

3.99

55.81

1.8

1.6

—

(3026008) Bacteria identified in Urine by Culture

1211

8069

1.87

55.44

3.9

3.4

—

(3029937) Albumin [Presence] in Urine by Test strip

992

6207

1.92

55.12

8.2

4.2

0.00

estimate

1.08

430

2022

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

853

5097

1.96

54.21

2.4

1.8

1.61

1.33

mg/l

1.39

699

3937

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

406

1819

2.44

53.79

1.9

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

169

462

3.83

53.78

5.3

3.4

61.80

58.19

2.69

169

462

(3033658) Prothrombin time (PT) actual/Normal

973

6100

1.90

53.38

5.9

3.9

92.85

87.99

6.80

951

5955

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1136

7496

1.86

52.98

3.1

2.5

79.37

59.40

u/l

0.50

1071

6897

(3005322) IgE [Units/volume] in Serum or Plasma

310

1236

2.69

52.32

1.5

1.2

209.20

206.45

u/ml

0.02

291

1138

(3020682) Albumin/Creatinine [Ratio] in Urine

1171

7837

1.84

51.89

7.7

3.8

22.79

8.84

mg/mmol

7.41

868

4874

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

125

280

4.62

51.81

1.5

1.2

4.21

5.76

u/ml

0.49

122

(3014148) Varicella zoster virus Ab [Titer] in Serum

103

197

5.39

51.32

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

183

546

3.51

51.13

1.7

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

138

338

4.24

51.05

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

140

6.30

50.69

2.3

2.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

418

1945

2.35

50.68

6.7

2.9

5.05

4.57

kpa

3.12

406

1885

(3004809) Band form neutrophils/100 leukocytes in Blood

156

422

3.85

50.37

3.3

3.6

1.10

1.47

0.72

150

375

(1175426) CD3 cells/100 lymphocytes in Blood

151

6.05

50.33

2.4

2.0

74.58

71.11

0.86

142

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

246

893

2.92

49.51

4.1

3.0

0.35

u/ml

0.08

152

518

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

200

651

3.23

48.61

4.7

2.4

3.47

3.63

g/l

0.66

193

612

(3000494) Fungus identified in Specimen by Culture

517

2682

2.13

47.85

1.9

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.95

47.67

12.5

13.6

4.92

5.60

mmol/l

0.79

(3044927) Protein electrophoresis panel - Urine

111

242

4.73

47.55

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1232

8533

1.78

47.46

3.8

3.4

2.33

2.36

mmol/l

5.87

1094

7423

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

182

5.37

47.25

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

105

226

4.79

45.68

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

118

281

4.34

45.26

3.2

4.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1328

9496

1.75

45.01

5.4

3.9

43.41

50.92

ng/l

0.49

1047

6948

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1241

8719

1.75

44.66

8.0

4.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

439

2193

2.18

44.51

9.3

6.8

1.32

1.37

mmol/l

0.50

425

2147

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

192

5.08

44.49

2.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

116

278

4.31

44.13

1.7

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

164

501

3.41

44.11

1.2

3.84

3.85

mmol/l

0.06

151

473

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

140

388

3.74

43.62

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

140

388

3.74

43.62

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

118

295

4.13

42.45

1.5

1.2

9.31

3.56

u/ml

0.58

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

173

561

3.22

42.25

1.3

472.22

536.57

mg/l

1.57

162

529

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

332

1517

2.35

41.56

6.3

3.6

1.33

1.99

mmol/l

2.81

258

1118

(3019309) Folate [Moles/volume] in Red Blood Cells

788

4940

1.82

41.18

1.9

1.8

1162.33

1180.96

nmol/l

0.21

628

3686

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

343

1598

2.30

41.02

6.4

3.6

5.08

5.17

kpa

1.23

332

1515

(3017704) Immunofixation for Urine

139

5.67

40.84

1.3

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

341

1588

2.30

40.81

2.0

1.6

—

(40768804) Tissue Pathology biopsy report

1312

9559

1.69

39.89

2.4

2.2

—

(3023419) Bacteria identified in Sputum by Culture

135

388

3.60

39.86

2.7

2.6

—

(3009343) pH of Capillary blood

337

1578

2.29

39.77

6.4

3.6

7.42

7.41

0.27

188

(3000093) Morphology [Interpretation] in Blood Narrative

212

4.60

39.55

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

176

602

3.05

39.24

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

11.23

38.91

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

11.23

38.91

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

11.23

38.91

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

11.23

38.91

1.1

1.0

—

(3036489) Thrombin time

216

832

2.73

38.71

2.9

2.0

21.85

21.76

0.06

201

737

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

125

5.80

38.66

1.3

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

144

443

3.37

38.28

4.4

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

103

252

4.20

38.14

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

105

263

4.11

37.68

1.5

52.84

63.66

1.58

166

(3021788) Differential panel - Synovial fluid

136

408

3.45

37.60

1.6

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1388

10366

1.66

37.60

2.3

2.1

93.59

94.30

pmol/l

0.22

774

5242

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

195

4.62

36.96

2.5

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

7.17

36.89

1.3

—

(3022313) Gas panel - Capillary blood

265

1153

2.43

36.89

6.5

3.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2583

23061

2.29

36.79

39.3

15.2

23.69

24.99

mg/l

1.43

2452

18450

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

8.16

36.74

2.3

2.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

102

258

4.06

36.12

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

102

258

4.06

36.12

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

6.86

36.09

2.8

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

401

2087

2.07

36.06

5.8

4.0

1.22

1.23

mmol/l

1.00

378

1816

(21494890) Protein electrophoresis panel - 24 hour Urine

102

259

4.05

35.94

1.4

2.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

7.90

35.77

1.2

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1040

7277

1.68

35.74

3.7

3.1

37.64

35.01

u/l

0.21

992

6888

(3045424) Erythrocytes [Presence] in Urine

128

382

3.46

35.68

1.6

1.5

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

226

4.27

35.62

1.2

45.59

58.54

u/l

2.60

207

(3041096) Erythrocytes [Presence] in Urine by Automated

891

5989

1.71

35.58

6.9

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

895

6033

1.70

35.31

1.8

1.6

18.95

20.73

nmol/l

3.19

798

5089

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

158

543

3.02

34.91

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

158

543

3.02

34.91

1.4

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

172

621

2.88

34.79

3.5

2.4

214.64

196.04

1.67

165

587

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

509

2916

1.91

34.67

8.5

7.1

4.95

5.10

kpa

2.96

483

2773

(3027801) Oxygen [Partial pressure] in Arterial blood

509

2916

1.91

34.67

8.5

7.1

11.98

12.19

kpa

0.34

483

2773

(40761535) Cells panel - Urine sediment

394

2067

2.05

34.59

8.0

3.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.89

34.57

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

236

4.13

34.48

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

141

457

3.19

34.43

1.3

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

186

708

2.74

34.06

1.6

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

254

3.96

33.58

4.7

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

103

277

3.82

33.51

2.7

2.2

1.23

1.48

g/24h

0.34

136

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

4.79

32.99

1.8

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

123

377

3.36

32.88

1.2

—

(3045414) Leukocytes [Presence] in Urine

241

1061

2.39

32.59

2.4

2.0

—

(3016502) Oxygen saturation in Arterial blood

459

2590

1.92

32.57

8.9

7.6

95.69

95.51

0.23

440

2492

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

228

985

2.43

32.14

6.8

3.9

24.57

24.88

mmol/l

0.89

215

909

(3004119) Hemoglobin [Mass/volume] in Venous blood

315

1560

2.15

32.10

6.7

3.0

120.26

127.94

g/l

7.14

309

1517

(3019832) Treponema pallidum Ab [Presence] in Serum

260

1194

2.30

31.89

1.5

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.18

31.62

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

8.97

31.59

1.4

—

(3003396) Base excess in Arterial blood by calculation

498

2915

1.86

31.46

8.6

7.1

0.93

1.15

mmol/l

0.61

400

2299

(3006245) CD3-CD19+ cells/100 cells in Blood

7.36

30.96

3.8

2.1

8.57

11.16

0.38

(3000060) B lymphocytes [#/volume] in Blood

9.36

30.94

2.9

1.9

117.14

163.75

e6/l

0.39

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

6.29

30.89

1.6

2.5

80656.42

30371.31

u/ml

0.26

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

145

509

2.95

30.85

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

7.24

30.53

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

513

2.92

30.41

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

150

548

2.83

29.67

1.7

1.6

9780.98

17235.95

e6/l

1.78

115

387

(3042631) Mycobacterium sp identified in Specimen

114

357

3.28

29.45

3.2

2.8

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

265

3.67

29.33

2.9

3.6

59.85

56.97

0.60

224

(3052851) Hemolysis interference index of Serum or Plasma

181

747

2.52

28.11

4.1

3.6

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

103

5.43

28.07

1.5

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

137

493

2.87

27.86

1.3

1.4

16.48

28.52

e6/l

0.39

105

380

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

137

493

2.87

27.86

1.3

1.4

1134.21

944.31

e6/l

0.08

114

400

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

138

4.72

27.82

1.9

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

138

4.72

27.82

1.9

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

428

2481

1.85

27.61

2.3

2.2

207.04

144.52

ug/g

1.43

358

1946

(3002173) Hemoglobin [Mass/volume] in Arterial blood

415

2387

1.86

27.43

9.6

7.9

115.72

120.81

g/l

5.53

403

2317

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

206

3.92

26.87

1.9

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

446

2646

1.81

26.62

4.3

3.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

290

1491

2.05

26.60

1.6

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

226

3.75

26.56

1.2

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

350

1927

1.93

26.40

3.5

2.7

54.05

62.60

ml/min/173m2

3.65

175

809

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

161

4.30

26.32

1.3

1.2

2.09

2.07

mmol/l

0.07

152

(3024471) HLA-A [Type]

7.18

26.29

1.0

—

(3019225) pH of Specimen

434

2577

1.81

25.77

8.8

4.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

255

1269

2.11

25.49

6.8

3.1

24.96

25.31

mmol/l

0.95

247

1228

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

722

4937

1.62

25.42

5.2

3.8

208.95

555.35

ng/l

1.14

601

4051

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.23

25.04

3.4

7.0

94.66

66.86

mg/l

0.53

(3007566) Smooth muscle Ab [Titer] in Serum

142

552

2.65

24.93

1.4

1.2

69.17

90.00

titre

0.55

(21494814) CD8 cells/100 lymphocytes in Specimen

5.54

24.61

2.4

1.9

—

(3024932) HLA-DR beta [Type]

7.06

24.60

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

314

3.20

24.42

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

134

4.47

24.09

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1034

7756

1.52

23.94

3.4

2.5

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

143

4.34

23.93

1.2

1.1

37.69

42.42

mg/l

0.41

125

(3030981) Hyaline casts [#/volume] in Urine by Automated count

249

1262

2.07

23.68

5.8

2.7

0.16

0.33

e6/l

2.25

244

1232

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

4.46

23.62

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

259

1335

2.03

23.52

10.6

9.3

24.42

24.37

mmol/l

0.09

246

1292

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1406

11266

1.49

23.48

3.4

2.6

—

(40768443) Skin Pathology biopsy report

218

1059

2.15

23.16

1.3

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

139

558

2.57

22.87

1.4

1.2

680.00

1113.08

titre

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

136

4.33

22.76

1.1

257.39

290.98

mg/l

0.62

122

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

378

2235

1.80

22.59

2.5

2.4

34.61

60.05

u/l

0.62

323

1904

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

694

4844

1.57

21.91

2.8

3.1

2.47

2.46

mmol/l

1.34

611

4265

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

136

4.26

21.88

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

233

3.41

21.77

1.2

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

331

2.97

21.13

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

818

5963

1.52

21.07

3.2

2.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

5.54

21.02

1.1

1606.13

1665.32

miu/ml

0.11

(3017732) Neutrophils [#/volume] in Blood

277

1520

1.91

20.94

3.2

3.1

5.15

5.08

e9/l

0.05

208

1193

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

276

3.14

20.75

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

124

494

2.58

20.74

1.7

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

4.80

20.58

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

501

3281

1.64

20.47

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

22.52

20.36

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

5.00

20.18

1.3

1.1

66.86

8.20

u/ml

—

(3002385) Erythrocyte distribution width [Ratio]

2199

19572

1.54

20.09

39.8

18.2

15.27

15.17

0.40

2180

19193

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.40

19.95

2.2

1.8

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

165

761

2.24

19.93

1.4

1.3

—

(1616796) Gas panel - Central venous blood

134

566

2.43

19.81

5.4

4.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

198

986

2.08

19.69

2.2

1.8

—

(3024928) Oxygen saturation in Venous blood

125

515

2.49

19.50

6.3

2.6

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

40.37

19.49

2.2

1.0

438.57

—

titre

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

210

3.39

19.44

1.6

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

210

3.39

19.44

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

210

3.39

19.44

1.6

1.5

—

(3008898) HLA-B27 [Presence]

137

591

2.38

19.34

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

123

4.20

19.33

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

373

2294

1.72

19.28

2.9

2.4

5.48

6.96

ug/l

1.30

315

2001

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

420

2668

1.67

19.24

2.7

7.34

8.98

umol/l

1.08

364

2344

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

128

4.12

19.19

1.3

1.1

25.07

18.49

u/l

0.68

109

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

203

3.41

19.03

1.5

31.82

30.30

0.11

125

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1519

12654

1.43

18.97

3.1

2.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

3.42

18.90

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

4.24

18.82

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

117

4.24

18.82

1.1

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

331

2.84

18.78

7.7

6.6

12.42

11.95

mg/l

0.39

305

(3027315) Oxygen [Partial pressure] in Blood

134

580

2.38

18.78

5.8

5.0

8.53

8.45

kpa

0.19

134

572

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

7.36

18.65

1.3

2.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

118

4.21

18.62

1.2

1.1

1.07

1.19

u/l

0.81

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

329

2.82

18.41

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

5.98

18.23

1.1

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

266

3.03

18.16

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

206

1073

1.99

18.10

2.4

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

4.82

18.00

1.1

204.37

523.80

ng/l

0.44

(3019060) Gas panel - Arterial blood

292

1713

1.79

17.75

4.9

4.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

106

4.30

17.60

1.2

1.1

1.07

1.05

ratio

0.51

(3012501) Base excess in Blood by calculation

131

579

2.32

17.51

5.8

5.0

2.32

2.81

mmol/l

1.42

101

405

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

199

3.32

17.51

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

131

580

2.32

17.45

5.8

5.0

4.95

5.08

kpa

1.48

131

573

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2365

21583

1.56

17.38

7.6

6.1

40.71

40.31

mmol/mol

1.08

2249

19719

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

373

2362

1.67

17.19

2.4

2.1

0.23

0.21

g/l

3.74

347

2200

(3049717) Cytology report of Urine Cyto stain

190

982

2.00

17.06

2.7

2.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

123

3.95

16.81

3.5

3.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

106

4.20

16.73

1.3

6.22

3.36

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

465

3130

1.58

16.68

1.5

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2583

24142

1.75

16.66

35.8

18.1

139.37

139.64

mmol/l

5.86

2553

23512

(3003327) Ova and parasites identified in Stool by Light microscopy

139

644

2.22

16.63

1.9

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

127

567

2.30

16.60

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1668

14325

1.40

16.33

3.9

3.1

57.24

51.82

u/l

1.05

1577

13143

(3010838) Calcium [Moles/time] in 24 hour Urine

104

431

2.47

16.06

1.5

1.9

4.42

4.91

mmol/24h

0.76

359

(3023103) Potassium [Moles/volume] in Serum or Plasma

2584

24193

1.73

16.03

36.5

18.2

3.99

3.98

mmol/l

0.37

2548

23520

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

120

3.88

15.73

1.3

1.7

—

(40761536) Microorganisms panel - Urine sediment

319

1988

1.68

15.56

9.1

4.2

—

(3019150) Specific gravity of Urine by Refractometry

687

5089

1.46

15.55

8.0

4.3

1.02

kg/l

0.38

761

(3010421) pH of Blood

143

689

2.13

15.52

6.1

4.6

7.43

7.42

1.00

134

625

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

291

2.76

15.48

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1992

17715

1.41

15.38

4.6

4.0

15.21

14.93

pmol/l

5.04

1837

15894

(3011436) Histone Ab [Units/volume] in Serum

6.46

15.37

1.2

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

162

3.38

15.06

1.4

1.1

—

(3028433) Virus identified in Specimen by Culture

4.49

14.94

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

133

3.58

14.33

1.9

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

133

3.58

14.33

1.9

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

6.00

14.32

1.8

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

133

646

2.11

14.16

4.8

3.1

23.95

25.01

mmol/l

2.40

133

631

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2365

21818

1.49

14.11

29.5

14.5

71.57

76.93

ml/min/173m2

21.42

2165

18008

(40767503) Oxygen content in Capillary blood by calculation

117

541

2.21

14.10

3.2

2.5

15.71

16.04

0.41

263

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

4.08

13.99

1.2

—

(3025941) Bacteria identified in Stool by Culture

215

1242

1.79

13.72

1.4

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

105

3.85

13.60

1.7

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.96

13.57

1.1

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

626

4661

1.44

13.53

1.3

1.2

1.45

1.37

u/ml

0.08

152

1182

(40761511) CBC panel - Blood by Automated count

2535

23787

1.60

13.49

29.1

14.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

227

1340

1.75

13.45

11.7

10.1

—

(3051651) Icteric interference index of Serum or Plasma

154

3.29

13.41

4.0

3.8

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

348

2299

1.59

13.36

3.3

3.0

228.80

214.29

ng/l

0.22

319

2105

(3013293) Extractable nuclear Ab [Presence] in Serum

18.30

13.36

2.5

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

5.13

13.15

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

123

3.53

12.93

2.5

2.7

39.52

40.29

0.07

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

4.87

12.84

1.0

1.1

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2589

24474

1.63

12.67

38.3

18.1

97.25

78.81

umol/l

30.66

2589

24465

(3010144) Erythrocytes [#/volume] in Synovial fluid

208

2.88

12.60

1.5

1.3

12122.08

100744.30

e6/l

1.15

145

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

114

547

2.13

12.55

1.5

1.4

—

(3020891) Body temperature

184

1042

1.82

12.55

6.7

4.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

17.38

12.50

1.2

1.0

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

177

3.03

12.45

1.5

12.69

13.18

u/l

0.21

167

(3023410) Appearance of Cerebral spinal fluid

232

2.75

12.41

1.5

—

(3000012) Reticulocyte production index

372

2.35

12.16

3.1

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.25

12.01

1.6

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

451

2.21

11.99

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

319

2.45

11.98

1.5

1.4

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

13.42

11.93

1.0

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

327

2.42

11.83

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

321

2.44

11.83

1.5

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

9.65

11.72

1.6

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

323

2.42

11.67

1.5

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2584

24490

1.59

11.61

24.1

10.7

24.15

25.32

u/l

3.05

2554

23493

(3024522) Salmonella sp identified in Specimen by Organism specific culture

324

2.41

11.60

1.5

1.4

—

(3022145) Colonoscopy Study observation

375

2599

1.51

11.54

1.3

—

(3013512) EKG study

916

7427

1.34

11.54

5.2

4.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

319

2.42

11.51

1.5

1.4

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.14

11.32

1.0

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.14

11.26

1.2

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.14

11.26

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

130

684

1.94

11.15

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

105

512

2.09

11.12

1.6

2.7

26.89

35.42

umol/l

5.62

455

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

116

3.39

11.09

4.4

4.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

135

722

1.91

11.04

1.5

1.4

279.24

274.16

ug/g

0.10

421

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

8.58

11.01

1.1

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

251

1608

1.62

10.92

8.7

6.7

24.05

24.54

mmol/l

1.16

240

1526

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

180

2.87

10.91

1.1

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

676

1.94

10.87

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

130

691

1.92

10.83

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

129

3.21

10.68

1.5

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

129

3.21

10.68

1.5

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

145

3.07

10.62

1.6

1.5

6.45

6.83

u/l

0.05

121

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

4.25

10.55

1.4

1.6

0.20

0.43

ug/l

1.94

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

120

3.28

10.53

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

374

2.23

10.30

1.8

1.4

—

(4200892) Spirometry reversibility

258

1687

1.58

10.30

1.6

1.4

—

(3047189) Immunofixation for 24 hour Urine

127

3.18

10.28

1.3

1.6

—

(4035726) Immunohistochemistry procedure

317

2196

1.50

9.72

1.4

—

(3026389) Candida sp identified in Specimen by Organism specific culture

313

2.30

9.69

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.59

9.65

1.2

—

(3034426) Prothrombin time (PT)

4.19

9.63

1.2

1.3

—

(3021901) Oxygen saturation in Capillary blood

473

2.04

9.56

3.6

2.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

160

2.84

9.54

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.03

9.50

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2283

21305

1.36

9.50

5.6

4.9

1.88

2.04

mu/l

1.84

2116

19239

(3028271) Lactate [Moles/volume] in Capillary blood

421

2.10

9.45

2.4

1.9

1.71

1.68

mmol/l

0.15

410

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

4.13

9.43

1.3

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

210

1336

1.62

9.41

2.5

2.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

4.69

9.29

1.3

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

157

2.83

9.27

1.4

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

105

552

1.94

9.09

2.9

2.2

125.80

128.16

g/l

0.52

409

(3044889) 12 lead EKG panel

1839

16695

1.29

9.08

4.8

4.0

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

116

3.13

9.06

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

116

3.13

9.06

1.4

—

(3000492) Spirometry study

292

2018

1.50

9.05

1.8

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

10.05

9.01

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

248

1659

1.54

8.96

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

274

2.33

8.89

4.0

3.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.93

8.86

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.93

8.86

1.1

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.03

8.78

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

2.77

8.55

1.5

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

132

2.90

8.43

1.9

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

2.90

8.43

1.9

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

3.99

8.33

2.0

3.1

10.85

7.34

mg/l

1.26

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.76

8.28

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.08

8.24

1.3

1.2

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

3.28

8.20

2.4

1.7

66.27

62.70

ug/l

0.08

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

673

5439

1.31

8.17

1.8

1.7

30877662.43

30293956.70

pmol/l

0.01

570

4463

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.55

8.11

1.4

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.77

8.06

1.3

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.05

7.87

2.8

3.5

—

(3011985) Renin [Units/volume] in Plasma

290

2.20

7.82

1.4

1.3

169.54

44.16

mu/l

0.76

261

(3019174) dRVVT (LA screen)

8.46

7.80

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

3.79

7.79

2.0

2.5

216.74

181.20

0.68

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

253

2.28

7.73

4.6

2.7

—

(3024263) Appearance of Synovial fluid

129

2.81

7.58

1.5

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

6.70

7.58

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

181

2.51

7.58

1.1

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

111

634

1.78

7.46

3.5

3.3

0.86

0.81

nmol/l

0.31

490

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.67

7.46

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

161

1019

1.61

7.41

1.4

1.3

—

(3045142) Bone marrow Pathology biopsy report

291

2.16

7.36

1.2

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.40

7.24

1.2

0.38

0.30

g/l

4.42

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

15.77

7.22

4.5

4.9

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

15.77

7.22

5.8

5.0

462.00

393.57

umol/l

—

(21494434) Karyotype in Bone marrow

230

2.28

7.13

1.1

1.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

129

784

1.68

6.97

5.5

3.7

4.03

3.89

mmol/l

2.14

129

777

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

5.46

6.90

1.8

1.3

132.87

108.80

ng/l

0.32

(3011648) Oxygen content in Venous blood

196

2.37

6.88

5.6

1.7

10.73

11.02

0.21

196

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.35

6.82

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

152

2.52

6.52

1.4

1.2

0.77

1.01

u/ml

0.14

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

102

2.86

6.36

2.0

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

102

2.86

6.36

2.0

1.7

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.17

6.31

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.26

6.27

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

103

2.83

6.26

2.1

1.7

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

7.03

6.21

1.3

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

159

1051

1.54

6.12

5.8

5.3

0.88

0.05

149

985

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

191

2.27

5.90

1.3

12.00

11.02

u/l

0.22

175

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

536

1.74

5.85

1.5

1.9

5.25

4.38

iu/l

0.20

177

(3017569) Oxygen content in Arterial blood

119

2.62

5.80

2.0

2.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.14

5.79

3.2

4.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

11.14

5.79

1.7

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

738

6261

1.24

5.75

1.8

1.6

1.39

1.36

mmol/l

0.47

634

5214

(3016038) Potassium [Moles/volume] in Urine

169

2.33

5.67

1.2

32.75

35.72

mmol/l

0.39

146

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

157

1061

1.51

5.49

5.9

5.3

1.51

1.59

0.55

147

992

(3014051) Protein [Presence] in Urine by Test strip

106

654

1.64

5.48

4.2

2.7

—

(3019977) pH of Arterial blood

135

2.46

5.45

3.9

2.7

7.43

0.33

(3048879) Bone marrow aspiration report

2.96

5.41

1.8

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

189

1330

1.45

5.40

3.1

3.3

4.23

4.43

pmol/l

1.73

161

1173

(3009542) Hematocrit [Volume Fraction] of Blood

2614

25339

1.38

5.33

50.6

22.7

38.79

39.63

10.88

2470

23497

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.19

5.31

1.5

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.73

5.29

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

2616

25370

1.38

5.24

50.5

22.7

128.52

133.76

g/l

61.15

2595

24943

(3028468) Fragments [Presence] in Blood by Light microscopy

+∞

5.21

4.0

0.0

—

(3007461) Platelets [#/volume] in Blood

2614

25352

1.38

5.19

50.3

22.6

263.37

247.85

e9/l

23.28

2584

24637

(3024731) MCV [Entitic volume]

2614

25359

1.37

5.11

50.1

22.5

91.98

91.34

10.00

2594

24927

(3035941) MCH [Entitic mass]

2614

25361

1.37

5.09

50.0

22.5

30.24

30.35

2.27

2594

24927

(3010813) Leukocytes [#/volume] in Blood

2614

25362

1.37

5.08

50.3

22.6

7.67

6.76

e9/l

60.79

2578

24561

(3026361) Erythrocytes [#/volume] in Blood

2614

25362

1.37

5.08

50.3

22.6

4.29

4.44

e12/l

41.83

2577

24557

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

272

1.97

5.07

1.2

1.3

466.42

305.16

pmol/l

0.97

236

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2268

21622

1.24

5.00

4.8

4.1

1.34

1.29

mmol/l

2.57

2087

19428

(3001686) Cold agglutinin [Titer] in Serum or Plasma

3.35

4.88

1.2

1.4

—

141.25

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.85

4.80

1.3

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.85

4.80

1.3

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.85

4.80

1.3

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

9.02

4.78

1.0

—

(3003694) ABO and Rh group [Type] in Blood

704

6044

1.22

4.78

1.5

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

337

1.83

4.70

1.6

1.5

1376.17

1526.56

e6/l

0.19

244

(3044009) aPTT.lupus sensitive (LA screen)

6.13

4.60

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

5.47

4.60

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

14.03

4.57

3.4

2.6

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

14.03

4.57

3.4

2.6

—

(3003181) Sodium [Moles/volume] in Urine

483

1.68

4.55

1.6

1.3

51.64

60.58

mmol/l

1.99

391

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

468

1.69

4.54

1.3

1.2

216.67

219.22

miu/ml

0.02

198

(3050794) Legionella sp Ab [Presence] in Serum

5.81

4.44

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1490

0.65

4.40

1.5

1.7

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2353

22607

1.23

4.33

5.4

4.6

4.57

4.60

mmol/l

0.49

2183

20647

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

983

0.57

4.32

1.3

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

11.69

4.27

1.1

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

371

1.74

4.24

1.7

1.5

29.49

31.61

g/l

0.72

338

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.85

4.22

1.1

1.3

114.17

85.39

—

(3045788) Cell count panel - Pleural fluid

263

1.88

4.17

1.7

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.92

4.17

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.94

4.16

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

552

1.59

4.11

1.1

0.85

8.26

u/ml

—

(40768806) Pleura Pathology biopsy report

301

1.81

4.09

1.6

—

(3000330) Specific gravity of Urine by Test strip

179

1316

1.38

4.06

6.8

3.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

142

2.20

4.05

1.1

0.16

5.80

nmol/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

116

788

1.49

4.04

1.7

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2331

22413

1.22

4.03

5.4

4.5

1.52

1.47

mmol/l

5.67

2154

20330

(3012441) Differential panel - Pleural fluid

288

1.82

4.03

1.6

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

303

1.80

4.01

1.6

1.4

31177.18

84208.51

e6/l

0.86

179

(3009871) Measles virus Ab [Titer] in Serum

2.94

4.01

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.44

3.98

1.8

3.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.14

3.93

1.7

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

269

1.84

3.91

1.3

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.89

3.90

1.2

1.3

181.30

136.74

nmol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.97

3.84

10.6

8.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.07

3.80

1.1

1.0

—

(3002619) Bacteria identified in Specimen by Culture

3.19

3.77

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.77

3.77

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

12.02

3.76

1.3

1.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

4.15

3.70

1.0

1.3

6.07

329172.06

nmol/l

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

282

1.79

3.68

1.1

1.57

1.52

g/l

0.26

254

(3004775) Volume in Urine collected for unspecified duration

196

1.95

3.67

2.6

2.2

871.56

619.65

2.54

125

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

374

3086

1.24

3.66

5.1

4.7

33.24

33.10

0.09

300

2009

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

602

1.53

3.62

2.7

2.2

279.47

104.42

ug/min

1.24

355

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.51

3.60

1.3

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

322

1.72

3.57

1.3

0.12

0.41

nmol/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.66

3.56

1.1

92.33

85.34

—

(40757373) Influenza virus identified in Isolate

2.82

3.52

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

280

1.76

3.47

9.7

6.4

7.08

7.54

mmol/l

0.53

235

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

2.62

3.47

1.3

1.4

36.38

21.51

0.82

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.33

3.33

1.4

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.37

3.31

3.6

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

163

1.97

3.24

1.6

1.7

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.35

3.19

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.35

3.19

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.38

3.18

1.6

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.80

3.18

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

1364

0.69

3.14

1.2

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

283

1.71

3.09

1.3

—

nmol/l

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

5.01

3.05

1.5

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2387

23144

1.19

3.03

5.9

5.2

2.60

2.68

mmol/l

4.87

2220

21027

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.56

2.99

1.5

60.73

40.16

umol/l

0.55

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

226

1.78

2.99

1.5

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

127

2.06

2.96

1.5

1.8

4.55

2.21

u/field

0.80

(3022621) pH of Urine by Test strip

204

1609

1.29

2.95

4.5

3.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

826

0.62

2.94

1.8

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

295

1.67

2.94

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2331

22571

1.18

2.93

5.8

4.8

5.93

6.01

mmol/l

1.97

2162

20285

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.72

2.92

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.83

2.91

9.3

8.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

108

2.14

2.90

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.26

2.86

1.1

1.3

134.05

159.73

mmol/24h

0.92

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.45

2.79

1.0

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.65

2.79

1.3

1.2

1.23

1.55

mmol/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.58

2.78

1.7

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.35

2.75

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.32

2.74

5.3

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.32

2.74

5.3

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

309

1.63

2.73

1.1

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

6.01

2.70

1.2

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

4.22

2.67

2.3

3.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

4.22

2.67

4.5

7.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

328

1.60

2.63

2.7

2.3

25.77

24.02

mg/l

0.10

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.47

2.62

1.5

1.3

44.00

28.22

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.61

2.57

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

650

7233

0.87

2.56

3.3

3.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

171

1346

1.29

2.55

1.2

158.57

145.34

iu/ml

0.15

487

(3036782) Glucose [Moles/volume] in Pleural fluid

261

1.66

2.54

1.7

1.4

6.85

6.60

mmol/l

0.20

245

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

379

1.54

2.54

2.1

2.0

7721.68

2397.18

u/l

0.43

155

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

180

1429

1.28

2.51

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

619

1.42

2.51

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

2.03

2.46

1.5

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

137

1.91

2.45

1.7

2.2

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.56

2.44

1.1

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.24

2.44

2.1

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.18

2.41

1.1

1.0

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

3.64

2.36

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.64

2.36

1.1

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

161

1.81

2.35

3.6

1.7

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

322

2742

1.20

2.35

2.7

4.1

19.53

23.05

ug/l

0.10

255

2244

(3009214) Lutropin [Units/volume] in Serum or Plasma

419

1.49

2.35

1.4

15.45

10.39

u/l

1.13

338

(3047181) Lactate [Moles/volume] in Blood

108

809

1.35

2.31

6.4

6.2

1.27

1.31

mmol/l

0.19

711

(3032057) Clostridioides difficile [Presence] in Stool

2.38

2.29

2.4

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

716

0.65

2.27

2.8

1.7

11.67

4.15

mg/l

0.94

534

(3002256) Pathology report gross observation

365

3153

1.18

2.27

1.4

1.3

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.49

2.27

1.4

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.90

2.25

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.90

2.25

1.3

2.4

—

(3035880) pH of Pleural fluid

149

1.82

2.24

1.5

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.56

2.21

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

5.56

2.21

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.41

2.19

1.7

1.4

8.17

8.99

ug/l

0.46

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.34

2.18

1.3

1.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.01

2.14

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

324

1.52

2.09

4.6

2.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

131

1.84

2.08

2.1

1.3

1.16

1.11

nmol/l

0.07

102

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.91

2.07

1.7

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.08

2.06

1.2

2.8

58.00

160.19

umol/l

1.32

(3023323) Follitropin [Units/volume] in Serum or Plasma

600

1.38

2.06

1.4

30.19

31.30

iu/l

0.11

512

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.41

2.02

1.1

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.41

2.02

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.11

2.02

1.1

1.2

28.80

39.15

g/l

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.08

2.01

1.1

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

263

1.57

2.00

1.1

7.90

2.11

u/ml

0.40

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.15

1.98

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.34

1.96

1.4

1.5

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.96

1.1

2.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.34

1.96

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

202

1.64

1.95

1.5

18.71

19.98

u/ml

—

(3039000) Anion gap in Blood

567

1.37

1.89

7.4

7.3

11.97

11.22

mmol/l

1.22

507

(3018572) Chloride [Moles/volume] in Blood

567

1.37

1.89

7.4

7.3

104.71

105.03

mmol/l

0.25

507

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.65

1.86

2.0

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

361

3172

1.16

1.84

12.7

7.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

485

1.39

1.83

1.7

1.6

367.63

300.79

mu/l

0.50

447

(3006462) Nitrate [Presence] in Urine

115

1.83

1.82

6.5

3.9

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.58

1.80

2.0

2.3

—

(3020393) Adenovirus Ag [Presence] in Stool

3.05

1.80

1.3

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

169

1.66

1.77

2.4

2.1

7.77

11.17

umol/l

0.39

116

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.85

1.71

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

693

1.31

1.68

5.6

4.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

790

7334

1.11

1.65

4.8

5.2

3.59

3.21

ug/l

0.12

690

6523

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.25

1.63

2.7

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

2.25

1.63

1.1

1.4

—

(4281824) Cell count and differential, peritoneal fluid

263

0.53

1.60

1.3

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.50

1.59

7.1

8.0

—

(3004451) EKG impression Narrative

137

1.68

1.55

1.7

1.3

—

(40758292) HTLV I+II Ab panel - Serum

2.43

1.53

1.1

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

162

1.61

1.49

3.6

2.5

—

(3008295) Osmolality of Serum or Plasma

269

1.46

1.44

1.5

1.3

278.21

277.39

mosm/kgh2o

0.07

198

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.13

1.44

1.0

—

(40768795) Lymph node Pathology biopsy report

230

1.48

1.39

1.3

1.2

—

(3022689) Creatine [Moles/volume] in Urine

2.00

1.38

2.6

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

2.20

1.37

1.4

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.78

1.33

1.3

1.6

30.38

29.92

umol/l

0.07

(3036180) Methadone [Presence] in Urine

2.04

1.32

2.1

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

636

0.73

1.30

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.94

1.27

1.8

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.94

1.27

1.1

1.6

65.08

198.68

nmol/24h

0.70

(3005570) Glucose [Moles/volume] in Urine

245

1.43

1.23

1.5

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

163

1.54

1.23

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

212

1.47

1.22

1.8

1.3

30.82

28.56

u/l

0.12

170

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

629

1.26

1.21

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

132

1.60

1.20

2.7

2.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

101

1.69

1.19

1.1

1.0

—

(3000285) Sodium [Moles/volume] in Blood

2.11

1.18

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

344

0.67

1.15

1.5

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

275

1.39

1.13

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.34

1.12

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.08

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

263

1.37

1.03

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

264

1.37

1.01

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

162

1412

1.16

1.01

1.6

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

155

1.49

1.01

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.97

0.0

2.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.22

0.93

1.8

1.3

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.67

0.91

1.0

1.3

652.90

480.42

ug/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

628

1.22

0.90

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.91

0.88

1.0

1.3

—

(3015183) Erythrocyte sedimentation rate

1.61

0.87

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

129

1.48

0.83

1.1

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

202

0.64

0.82

1.5

—

(3025130) Human papilloma virus identified in Specimen

214

1.36

0.82

2.0

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.88

0.81

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

472

1.23

0.81

2.3

1.6

1.00

0.81

nmol/l

1.08

385

(3000034) Microalbumin [Mass/volume] in Urine

224

1.34

0.80

5.0

3.0

83.52

28.13

mg/l

0.86

167

(44816559) Phosphatidylethanol [Mass/volume] in Blood

358

1.26

0.77

1.2

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.00

0.72

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

159

1.39

0.72

1.2

1.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

276

0.72

0.71

1.5

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

144

0.62

0.69

1.1

—

(4212803) Bone marrow aspirate examination

1.79

0.66

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

340

1.24

0.65

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

615

5872

1.06

0.64

4.1

4.5

21.32

21.77

0.33

309

2958

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

106

935

1.14

0.63

2.9

3.3

53.94

4556.13

u/ml

0.89

795

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

142

1276

1.12

0.63

1.6

1.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

212

0.71

0.63

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

175

0.68

0.60

1.0

1.1

8.40

3.74

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.54

0.59

2.5

2.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

363

1.22

0.59

1.2

1.1

28.57

1627.43

iu/ml

—

(37021550) Renin [Units/volume] in Plasma --upright

1.51

0.58

1.0

1.2

50.86

41.81

mu/l

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

227

0.75

0.53

1.0

0.70

1.57

u/ml

—

121

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

108

1.39

0.53

1.1

1.3

5.70

6.15

mmol/l

0.90

103

(3020717) Zinc [Moles/volume] in Serum or Plasma

100

1.40

0.51

1.7

1.4

11.06

21.89

umol/l

3.58

(4146454) Self-monitoring of blood glucose

287

1.22

0.51

3.1

2.6

—

(40768800) Prostate Pathology biopsy report

486

0.84

0.48

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

217

1.25

0.48

1.8

2.2

0.75

2.14

u/field

2.06

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

199

1.26

0.48

1.8

1.6

0.22

0.33

nmol/l

1.44

157

(40765096) Chromosome analysis panel by Banding

1.41

0.46

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

1.43

0.46

1.0

1.4

—

(3011288) Drugs identified in Urine by Screen method

308

0.81

0.44

4.7

2.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

131

1.30

0.42

1.4

1.5

0.79

0.96

g/l

1.72

131

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

194

1.24

0.42

3.6

5.0

22.23

64.77

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.52

0.41

1.0

—

(3011048) Pyruvate [Moles/volume] in Blood

0.00

0.41

0.0

1.2

—

97.60

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

700

1.12

0.41

1.6

1.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

3.80

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

182

0.77

0.39

1.3

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

238

2251

1.06

0.38

1.5

1.7

1.68

1.50

1.81

204

1931

(3017446) Testosterone [Moles/volume] in Serum or Plasma

152

1416

1.08

0.38

2.0

2.2

13.22

12.43

nmol/l

0.54

126

1252

(3009466) Valproate [Moles/volume] in Serum or Plasma

327

1.16

0.37

3.4

4.9

302.24

361.84

umol/l

1.33

283

(3033799) Differential panel - Peritoneal fluid

0.63

0.35

1.8

2.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

255

0.82

0.35

1.6

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

244

0.82

0.35

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

243

0.82

0.33

1.4

—

(3051101) Glucose [Moles/volume] in Cord blood

1.33

0.33

3.8

5.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

242

0.83

0.32

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

242

0.83

0.32

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.29

0.31

1.2

1.4

—

(3016879) Cocaine [Presence] in Urine

418

1.13

0.31

2.1

2.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

434

4201

1.04

0.30

3.0

3.2

0.68

0.77

ug/l

1.58

330

2877

(3023511) Choriogonadotropin [Units/volume] in Urine

194

1.19

0.29

1.4

1.2

—

(4034850) Laboratory test

785

0.92

0.29

24.3

10.9

—

(3014271) Vancomycin [Susceptibility]

150

1.20

0.26

3.3

2.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

414

0.89

0.25

1.6

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

349

1.12

0.25

2.3

2.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

179

1.17

0.25

1.0

41.43

45.81

ng/l

0.21

111

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

264

1.14

0.24

1.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

180

1.17

0.23

1.0

661.38

674.07

ng/l

0.06

111

(3051387) C reactive protein [Mass/volume] in Capillary blood

556

0.92

0.22

8.3

3.6

34.74

27.16

mg/l

0.82

348

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.25

0.22

1.8

1.2

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.55

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.20

0.0

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.22

0.20

1.5

2.7

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

317

1.11

0.19

2.4

2.2

3.18

1399.57

u/ml

0.89

311

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.13

0.18

1.0

1.1

—

6.00

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.21

0.18

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.19

0.18

2.0

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.15

0.17

1.3

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

204

0.88

0.16

1.5

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

178

1.12

0.15

1.0

326.08

325.60

ng/l

0.00

112

(3006442) Creatine [Moles/volume] in Serum or Plasma

169

1.13

0.14

1.2

1.5

87.63

85.27

umol/l

0.17

169

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

0.79

0.14

1.0

—

4.23

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.18

0.14

1.3

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

159

1540

1.03

0.14

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

295

0.91

0.14

1.1

2.81

1.90

u/ml

0.15

155

(3028707) Methadone [Presence] in Urine by Screen method

199

1.11

0.13

3.2

2.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

113

1.15

0.13

1.3

76.60

156.94

pmol/l

2.84

113

(3047352) Trisomy 18 risk [Likelihood] in Fetus

200

0.90

0.12

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

114

1.14

0.11

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

108

1044

1.04

0.11

1.1

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

445

1.06

0.11

2.2

2.0

—

(40768441) Liver Pathology biopsy report

153

1.11

0.11

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

465

1.05

0.11

1.5

1.7

51.07

41.42

nmol/l

1.56

443

(3005033) Fetal Nuchal fold Thickness US

198

0.91

0.10

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.06

0.09

1.0

—

(3028300) Cannabinoids [Presence] in Urine

449

1.05

0.08

2.2

2.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

136

1.10

0.08

4.9

6.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.03

0.08

1.2

1.3

—

(3027944) Amphetamines [Presence] in Urine

440

1.05

0.08

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.84

0.07

1.0

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.12

0.07

1.0

1.3

—

(3003338) MCHC [Mass/volume]

1882

18859

0.99

0.05

45.5

20.0

328.47

331.72

g/l

42.99

1870

18703

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

160

1.06

0.04

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

317

3194

0.99

0.04

1.5

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

111

1.08

0.04

1.2

179.17

139.67

nmol/l

0.87

111

(3027008) Opiates [Presence] in Urine

448

1.03

0.03

2.2

2.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

531

0.98

0.03

1.5

1.4

—

(40768793) Breast Pathology biopsy report

602

1.01

0.01

1.4

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

166

0.96

0.00

2.0

1.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

234

2334

1.00

0.00

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

131

0.99

0.00

13.2

14.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

141

0.99

0.00

1.3

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

246

1.02

0.00

1.0

1.1

0.28

1.79

u/ml

—

105

(1002224) Polysomnography panel

726

1.01

0.00

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

553

0.99

0.00

1.4

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

253

0.99

0.00

1.0

1.1

3.40

4.56

u/ml

—

120

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

12.86

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.61

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1484.17

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

100

1.00

-0.00

1.0

1.4

1.55

1.54

g/l

—

100

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.85

-0.00

1.6

1.5

20.24

27.28

g/l

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.8

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.01

-0.00

2.4

2.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: M13_NECROVASC – Other necrotizing vasculopathies

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other necrotizing vasculopathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other necrotizing vasculopathies (M13_NECROVASC)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints